WO2005068434A1 - 2-pyrimidionxy-n-carbamidophenylbenzylamine compounds and processes of the preparation thereof and the use of the same - Google Patents

2-pyrimidionxy-n-carbamidophenylbenzylamine compounds and processes of the preparation thereof and the use of the same Download PDF

Info

Publication number
WO2005068434A1
WO2005068434A1 PCT/CN2004/000720 CN2004000720W WO2005068434A1 WO 2005068434 A1 WO2005068434 A1 WO 2005068434A1 CN 2004000720 W CN2004000720 W CN 2004000720W WO 2005068434 A1 WO2005068434 A1 WO 2005068434A1
Authority
WO
WIPO (PCT)
Prior art keywords
substituted
compound
mmol
catalyst
hydrogen
Prior art date
Application number
PCT/CN2004/000720
Other languages
French (fr)
Chinese (zh)
Inventor
Long Lu
Jie Chen
Yong Wu
Zhiping Jin
Xiaoyan Xu
Jun Yuan
Yan Zhang
Yonghua Wang
Original Assignee
Shanghai Institute Of Organic Chemistry, Chinese Academy Of Sciences
Zhejiang Chem-Tech Group Co., Ltd
Bayer Cropscience
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute Of Organic Chemistry, Chinese Academy Of Sciences, Zhejiang Chem-Tech Group Co., Ltd, Bayer Cropscience filed Critical Shanghai Institute Of Organic Chemistry, Chinese Academy Of Sciences
Publication of WO2005068434A1 publication Critical patent/WO2005068434A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms
    • C07D239/62Barbituric acids
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/08Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
    • A01N47/28Ureas or thioureas containing the groups >N—CO—N< or >N—CS—N<
    • A01N47/30Derivatives containing the group >N—CO—N aryl or >N—CS—N—aryl

Definitions

  • the present invention relates to a new class of 2-pyrimidinyloxy-N-ureidophenylbenzylamine compounds, a preparation method and uses thereof as agricultural chemical herbicides. Background technique
  • Pesticides are an indispensable means of production for humans to obtain food and ensure stable and high yields in agriculture.
  • pesticides such as pesticides, fungicides, and herbicides have made great contributions to civilization.
  • humans ’demand for food is also increasing, but the rate of cultivated land growth is far behind the rate of population growth.
  • Yield and improvement of crop quality require various means, such as breeding, cultivation, fertilization, and the application of pesticides is also one of the essential means.
  • Pyrimidinyloxybenzene derivatives can be used as chemical herbicides, such as Agr. Biol. Chem., Vol. 30, P896 (1966); Japanese patent 79-55729; US patents 4,248,619 and 4,427,437.
  • Representative examples include: Pyrithiobac-sodium (KIH-2031, European Patent 315889), Bispyribac-sodium (KIH-2023, European Patent 321846), Pyriminobac-methyl , KIH-6127, Japanese Patent 04368361), Pyribenzoxim (European Patent 658549), and Cyclopsalid (Pyriftalid, European Patent 768034), their mechanism of action is the same as that of sulfonylurea herbicides, all of which are acetyl Inhibitors of lactic acid synthase (ALS) disrupt the synthesis of amino acids such as valine, leucine and isoleucine in plants.
  • ALS acetyl Inhibitors of lactic acid synthase
  • pyrimidinesalicylic acid compounds have high herbicidal activity, they are currently only applicable to weeding in cotton and rice fields.
  • the present invention provides a new compound, that is, 2-pyrimidinyloxy-N-ureidophenylamine compounds, and also provides a method for preparing the above compounds and uses as an agricultural chemical herbicide.
  • the compound has the structural formula such as
  • the problem to be solved by the present invention is to provide a new compound, that is, a 2-pyrimidinyloxy-N-ureidophenylbenzylamine compound.
  • the problem to be solved by the present invention is to provide a method for preparing the aforementioned compound.
  • Another problem to be solved by the present invention is to provide a use of the above compound.
  • the invention provides a 2-pyrimidinyloxy-N-ureidophenylbenzylamine compound having the structural formula shown in (I):
  • D and E may be the same or different groups, which are hydrogen, halogen, Q—C 4 fluorenyl, —C 4 alkoxy, Q—C 4 haloalkyl, or Q—C 4 halofluorenyl, It is particularly preferred that both D and E are methoxy.
  • X is hydrogen, halogen, nitro, cyano, carboxyl, ester, sulfonyl, Q-C 8 fluorenyl, d-C 8 halofluorenyl, d-C 8 alkoxy, C plant C 8 acyl , D—C 8 amidamido, Q—C 8 haloalkanoyl, phenyl, benzoyl, substituted phenyl, heterocyclyl or substituted heterocyclyl, etc., it is recommended that X be H or methoxy, X be in benzene
  • the ring can be in any one, two, or more of the 3, 4, 5, and 6 positions.
  • X ' is H, ureido (H 2 Nl' N , R1 , the substituents on the ureido are and), halogen atom, carboxyl
  • X is mono-, di- or poly-substituted on the benzene ring.
  • R is H, n-butyl or n-butyl, n-butyl, or, connected to-(C3 ⁇ 4) 5-.
  • RR 2 is the same or different group.
  • the ureido group (() N. ⁇ —) can be in the ortho, meta or para position of the benzene ring, or it can contain ureido group and other substituents, such as halogen, carboxyl, ester group, —C 8 ⁇ group, — C halogenated alkyl with 8, a 3 ⁇ 4-alkoxy, d-C s alkyl group, a phenyl group, a substituted phenyl group, a heterocyclic group or substituted heterocyclic group.
  • R 3 hydrogen, d-C 8 amidino, d-C 8 haloalkanoyl, benzoyl, substituted benzoyl, d-C 8 amidino.
  • the substituted phenyl, substituted heterocyclic group or substituted benzoyl group is preferably halogen, nitro, cyano , a carboxyl group, an ester group, a sulfonyl group, d -C 8 alkyl, d- C mechanized. 8 haloalkyl group, d- embankment group, C factory wide. 8 C C C alkanoyl or alkanoylamino group and the like. 8; the Substituted phenyl, substituted heterocyclyl or substituted benzoyl are recommended as mono-, di- or poly-substituted.
  • the recommended compounds of the present invention have the following structural formula:
  • the starting material (II) in the reaction can be prepared by the following reaction:
  • R is halogen, nitro, cyano, carboxyl, ester, sulfonyl, —C 8 alkyl, —C 8 haloalkyl,. Broad alkoxy, Q_C 8 alkanoyl, or -C 8 amidamido and the like.
  • Intermediate ( ⁇ -1) synthesis can be prepared by reducing nitrophenyl urea. It can be prepared by reducing nitrophenyl urea with hydrogen under the action of a catalyst.
  • the catalyst can be Raney Ni, palladium carbon or For platinum black, etc., the molar ratio of substituted nitroaniline, hydrogen and catalyst is recommended to be 1: (1—1000): (0.01 -0.5).
  • the reaction temperature is recommended from room temperature to 40 ° C.
  • the reaction time is recommended from 0.5 to 10 hours.
  • the recommended solvents can be hydrocarbon solvents such as benzene, toluene or xylene; ether solvents such as tetrahydrofuran or dioxane; methanol, ethanol Or an alcohol solvent such as isopropyl alcohol; dimethylformamide, dimethylsulfoxide, acetonitrile, and a mixture of the above solvents can also be used, and the solvent of the reaction is more preferably an alcohol.
  • the intermediate (II-1) can also be prepared by reducing and replacing nitrophenylurea with hydrazine hydrate under the action of a catalyst.
  • the catalyst may be Raney Ni, etc., which replaces nitroaniline, hydrazine hydrate and the catalyst.
  • the molar ratio is recommended to be 1: (1 -1.5): (0.01-0.5), using more hydrazine hydrate has no effect on the reaction.
  • the reaction temperature is recommended to be room temperature to 40 ° C, and the reaction time is recommended to be 0.5 to 10 hours.
  • the recommended solvents can be hydrocarbon solvents such as benzene, toluene or xylene; ether solvents such as tetrahydrofuran or dioxane; methanol, ethanol or Alcohol solvents such as isopropyl alcohol; dimethylformamide, dimethyl sulfoxide, acetonitrile, and a mixture of the above solvents can also be used.
  • the solvent for this reaction is further recommended as an alcohol.
  • Nitrophenyl urea synthesis can be prepared by reacting nitrophenyl isocyanate with a substituted fatty amine, and the molar ratio is recommended to be 1: 1 to 1: 2.
  • the recommended solvent may be a hydrocarbon solvent such as benzene, toluene or xylene; an ether solvent such as tetrahydrofuran or dioxane; and the solvent for the reaction is further recommended as benzene.
  • the reaction temperature is preferably 5 ° C to room temperature, and the reaction time is preferably 0.5 to 12 hours.
  • Intermediate ( ⁇ -2) synthesis can be prepared by reducing nitrophenyl to replace aryl urea. Reduction conditions can be the same as those of intermediate ( ⁇ -1) synthesis.
  • Nitrophenyl substituted aryl synthesis can be performed by nitroaniline and substitution.
  • Aromatic isocyanate is prepared by reaction, and the molar ratio is recommended to be 1: 1 to 1: 1.5.
  • the recommended solvent may be a hydrocarbon solvent such as benzene, toluene, or xylene; an ether solvent such as tetrahydrofuran or dioxane; and the solvent for this reaction is further recommended as tetrahydrofuran.
  • the reaction temperature is preferably from room temperature to reflux, and the reaction time is preferably from 8 to 48 hours.
  • Intermediate ( ⁇ -3) synthesis can be prepared by reducing p-nitrophenyl fatty urea, and the reduction conditions can be the same as those of intermediate ( ⁇ -1).
  • the synthesis of p-nitrophenyl fatty urea can be performed by the following method Synthesis: Dissolve p-nitroaniline in hot glacial acetic acid, add sodium cyanate, the recommended molar ratio is 1: 1 to 1: 5, and filter to obtain p-nitrophenylurea.
  • the p-nitrophenyl urea is refluxed in dibutylamine or hexahydropyridine to obtain p-nitrophenyl fatty urea.
  • the method for synthesizing the starting material (II) containing a (X ′) n substituent on the benzene ring is the same as the above-mentioned reaction method.
  • the intermediate (III) can be synthesized by reacting ureido-substituted aniline ( ⁇ ) with salicylaldehyde or substituted salicylaldehyde.
  • the molar ratio is recommended to be 1: 0.8 ⁇ 2, and further recommended to be 1: 1 to 1: 2.
  • solvents can be hydrocarbon solvents such as benzene, toluene or xylene; halogenated hydrocarbon solvents such as dichloromethane, dichloroacetamidine, or chloroform; ether solvents such as tetrahydrofuran or dioxane; acetone or methyl isobutyl Ketone solvents such as ketones; alcohol solvents such as methanol, ethanol, or isopropanol; dimethylformamide, dimethyl sulfoxide, acetonitrile, and mixtures of the above solvents can also be used, and the solvents for this reaction are further recommended as alcohols.
  • hydrocarbon solvents such as benzene, toluene or xylene
  • halogenated hydrocarbon solvents such as dichloromethane, dichloroacetamidine, or chloroform
  • ether solvents such as tetrahydrofuran or dioxane
  • the reaction temperature is preferably from room temperature to the boiling point of the solvent, and the reaction time is preferably from 0.5 to 12 hours.
  • the reaction can be performed without a catalyst.
  • the addition of a catalyst can sometimes speed up the reaction speed and increase the reaction yield.
  • the catalyst used in the reaction can be p-toluenesulfonic acid, methanesulfonic acid, sulfuric acid, hydrochloric acid or acetic acid, etc. ( ⁇ The molar ratio of) to catalyst is recommended to be 1: 0.01-1.
  • the intermediate (IV) can be synthesized by reducing compound (III).
  • the reducing agent is recommended to be sodium borohydride or potassium borohydride.
  • the molar ratio of reactant (III) to reducing agent is recommended to be 1: 0.5-2.
  • the reaction temperature Recommended room temperature to 40 degrees Celsius, reaction time recommended 0.5 to 10 hours, recommended solvents can be hydrocarbon solvents such as benzene, toluene or xylene; ether solvents such as tetrachlorofuran or dioxane; methanol, ethanol or Alcohol solvents such as isopropanol; dimethylformyl- A mixture of amine, dimethyl sulfoxide, acetonitrile, and the above-mentioned solvents, and the solvent of the reaction is more preferably an alcohol.
  • the intermediate (IV) can also be prepared by reducing the compound (III) with hydrogen under the action of a catalyst.
  • the catalyst is recommended to be Raney Ni, palladium carbon, platinum black, etc., the reactant (II), hydrogen
  • the molar ratio to the catalyst is recommended to be 1: 1 to 1000: 0.01 -0.5. Using more hydrogen has no effect on the reaction.
  • the reaction temperature is recommended to be room temperature to 40 ° C, and the reaction time is recommended to be 0.5 to 10 hours.
  • the recommended solvents can be hydrocarbon solvents such as benzene, toluene or xylene; ether solvents such as tetrahydrofuran or dioxane; methanol, ethanol or Alcohol solvents such as isopropyl alcohol; dimethylformamide, dimethyl sulfoxide, acetonitrile, and a mixture of the above solvents can also be used.
  • the solvent for this reaction is more preferably an alcohol.
  • the base used is a hydride of a monovalent or divalent metal, an alkoxy metal compound or a carbonate thereof, such as sodium hydride, potassium hydride, calcium hydride ; Sodium methoxide or sodium ethoxide, potassium methoxide or potassium ethoxide; sodium carbonate, potassium carbonate, or calcium carbonate, etc .; or an organic base such as triethylamine, pyridine, or the like.
  • reaction solvents can be hydrocarbon solvents such as benzene, toluene or xylene; halogenated hydrocarbon solvents such as dichloromethane, dichloroacetamidine or chloroform; ether solvents such as tetrahydrofuran or dioxane; acetone or methyl isobutyl Ketone solvents such as methyl ketone; alcohol solvents such as methanol, ethanol, or isopropanol; dimethylformamide, dimethylsulfoxide, acetonitrile, and mixtures of the above solvents can also be used.
  • the best solvent for this reaction is ethers.
  • the reaction temperature is preferably from room temperature to the boiling point of the solvent, and the reaction time is preferably from 0.5 to 20 hours.
  • the molar ratio of intermediate (IV), 2-halo-4-D, 6-E-substituted pyrimidine or 2-methylsulfonyl-4-D, 6-E-substituted pyrimidine to base is recommended to be 1.0: 1.2 : 1-5.
  • the final product can be further purified by silica gel column chromatography or recrystallization.
  • alkyl, substituted fluorenyl, alkoxy, halofluorenyl, halofluorenyl, ester, alkanoyl, alkylamide, and haloalkylamide groups in the present invention refer to straight or branched chain.
  • the chain group is preferably 1 to 8 carbons, and further preferably 1 to 4 carbons.
  • the ester group mentioned in the present invention is preferably an alkoxycarbonyl group, a phenoxycarbonyl group or a substituted phenoxycarbonyl group with a carbon number of 1 to 8, and further an alkoxycarbonyl group, a phenoxycarbonyl group with a carbon number of 1 to 4 Or substituted phenoxycarbonyl group;
  • the sulfonyl group mentioned in the present invention is recommended to be an alkylsulfonyl group, a phenylsulfonyl group or a substituted phenylsulfonyl group, and further recommended to be a carbon number of 1 to 4 Alkylsulfonyl, phenylsulfonyl or substituted phenylsulfonyl;
  • the substituted phenoxycarbonyl or substituted phenylsulfonyl is recommended to be mono-, di- or poly-substituted, and the substituents are preferably halogen,
  • the compound of the present invention is used as an active ingredient of a pesticide chemical herbicide, and is formulated into various liquids, emulsifiable concentrates, suspensions, suspensions, microemulsions, (water) emulsions, powders, wettable powders, soluble powders, (water Dispersible) granules or capsules can be used for weed control in crops such as rice, soybean, wheat, cotton, corn and rape.
  • the weight percentage of the active ingredient in the preparation is recommended to be 5 to 90%, and the rest are carriers.
  • the carrier includes at least two kinds, at least one of which is a surfactant.
  • the carrier can be a solid or a liquid. Suitable solid carriers include natural or synthetic clays and silicates such as natural silica and diatomaceous earth; magnesium silicates such as talc; magnesium aluminum silicates such as kaolinite, kaolin, montmorillonite, and mica; white carbon black , Calcium carbonate, light calcium carbonate; calcium sulfate; limestone; sodium sulfate; amine salts such as ammonium sulfate, hexamethylene diamine.
  • Liquid carriers include water and organic solvents.
  • organic solvents can also be used as adjuvants or antifreeze additives.
  • Suitable organic solvents include aromatic hydrocarbons such as benzene, xylene, toluene, etc .; chlorinated compounds such as chlorobenzene, vinyl chloride, chloroform, dichloromethane, etc .; aliphatic hydrocarbons such as petroleum fractions, cyclohexane, light weight Mineral oils; alcohols such as isopropanol, butanol, ethylene glycol, glycerol and cyclohexanol; and their ethers and esters; and ketones such as acetone, cyclohexanone, and dimethylformamide And N-methyl-pyrrolidone.
  • Surfactants can be emulsifiers, dispersants or wetting agents; they can be ionic or non-ionic.
  • Non-ionic emulsifiers such as polyoxyethylene fatty acid esters, polyoxyethylene fatty alcohol ethers, polyoxyethylene fatty ammonia, and commercially available emulsifiers: agricultural milk 2201B, agricultural milk 0203B, agricultural milk 100 # , agricultural milk 500 # , Agricultural milk 600 # , Agricultural milk 600-2 # , Agricultural milk 1601, Agricultural milk 2201, Agricultural milk NP-10, Agricultural milk NP-15, Agricultural milk 507 # , Agricultural milk OX-635, Agricultural milk OX-622, Agricultural Milk OX-653, agricultural milk OX-667, Ning Ru 36 # .
  • Dispersants include sodium ligninsulfonate, pulverized powder, calcium ligninsulfonate, methylnaphthalenesulfonic acid methyl ester condensate, and the like.
  • Wetting agents are: sodium lauryl sulfate, sodium dodecylbenzenesulfonate, sodium alkylnaphthalenesulfonate, and the like.
  • preparations can be prepared by a general method.
  • the active substance is mixed with a liquid solvent and / or a solid carrier, and a surfactant such as an emulsifier, a dispersant, a stabilizer, a wetting agent is also added, and other auxiliary agents such as a binder, an antifoaming agent, and an oxidizing agent may be added.
  • a surfactant such as an emulsifier, a dispersant, a stabilizer, a wetting agent
  • other auxiliary agents such as a binder, an antifoaming agent, and an oxidizing agent may be added. Wait.
  • the herbicidally active compound of the present invention can be mixed with pesticides, fungicides, nematicides, plant growth regulators, fertilizers, and other herbicides or other agricultural chemicals.
  • the compound of the present invention and its preparation have the following characteristics and advantages:
  • a broad spectrum of weed control which can not only effectively control grass weeds in farmland, but also broad-leaved weeds and sedges. 3. It has good selectivity and is safe for certain crops, such as: wheat, soybean, cotton, rice, etc.
  • the residual period in the soil is short, and it has no adverse effect on the growth of subsequent crops.
  • the compound of formula (I) provided by the present invention has not only a simple synthetic method, but also herbicidal activity and crop selectivity, and can be used as a herbicide. Its preparation can effectively control most farmland weeds, and it can effectively control sensitive grasses, broad-leaved weeds, and sedges at lower doses.
  • Step 1 Take the synthesis of 1-p-nitrophenyl-3-diethylurea as an example: Under the protection of argon, add a 0.8 mL (5 mmol) to a 100 mL three-necked flask with a thermometer and a dropping funnel. ) P-nitrophenyl isocyanate and 5 mL of anhydrous benzene, 0.57 mL (5.5 mmol) of diethylamine dissolved in 5 mL of anhydrous benzene, cooled to 0-10 ° C, added dropwise to the reaction solution, and stirred after the addition About 30min, spin-dried and purified by column chromatography with a yield of 98%.
  • Second step Nitro reduction: 5 mmoll-p-nitrophenyl-3-diethylurea was dissolved in 20 mL of anhydrous methanol, 90 mg of Raney Ni was added, and 0.469 g (7.5 mmol) of 80% hydrated Add hydrazine dropwise to the reaction solution at room temperature Stir until the reaction is complete, TLC controls the end of the reaction. After filtration, the filtrate was spin-dried to obtain 1.035 g of 1-p-aminophenyl-3-diethylurea in a yield of 99%.
  • Step 1 Take the synthesis of 1-p-nitrophenyl-3- (2,4-difluorophenyl) urea as an example: Under the protection of argon, add 20 mL of anhydrous THF, 3 drops to a 50 mL Schlenck tube. Triethylamine and 1.38 g (10 mmol) of p-nitroaniline were dissolved in 1.20 mL (10 mmol) of 2,4-difluorophenyl isocyanate in 10 mL of anhydrous THF, and slowly added dropwise to the reaction solution at room temperature. Reflux until the reaction is complete, TLC controls the end of the reaction. Spin-dried and recrystallized from ethyl acetate in 52% yield.
  • Second step Nitro reduction: 5 mmoll-p-nitrophenyl-3- (2,4-difluorophenyl) urea was dissolved in 20 mL of anhydrous methanol, 90 mg of Raney Ni was added, and 0.469 g (7.5 80% of hydrazine hydrate was added dropwise to the reaction solution, and stirred at room temperature until the reaction was completed. TLC controlled the end of the reaction. After filtration, the filtrate was spin-dried to obtain 3.1 mmol of 1-p-aminophenyl-3- (2,4-difluorophenyl) urea in a yield of 62%.
  • Second step Nitro reduction: 5 mmoll-p-nitrophenyl-3-piperidinyl urea was dissolved in 20 mL of anhydrous methanol, 90 mg of Raney Ni was added, and 0.469 g (7.5 mmol) of 80% hydrated Hydrazine was added dropwise to the reaction solution and stirred at room temperature until the reaction was complete. TLC controlled the end of the reaction. After filtration, the filtrate was spin-dried to obtain 5 mmol of 1-p-aminophenyl-3-piperidinylurea in a yield of 99%.
  • Step 1 Condensation with salicylaldehyde: 4: 9 mmol of l-p-aminophenyl-3-diethylurea and 0.717 g (5.88 mmol) of salicylaldehyde are dissolved in 15 mL of methanol, and stirred at room temperature until the reaction Completely, TLC controls the endpoint of the reaction. Filtration gave 1.31 g of a yellow solid (III) in a yield of 86%.
  • Step 2 Schiff base reduction: Add 1.31 g of yellow solid (II) to 20 mL of absolute ethanol, add 0.242 g (6.18 mmol) of 97% sodium borohydride in portions, stir at room temperature for 30 min, and pour into ice Water, acetic acid The ethyl acetate was extracted three times, and the organic phases were combined, and the saturated brine and water were washed once, dried over anhydrous sodium sulfate, filtered and spin-dried to obtain the product (IV), with a yield of 99%.
  • Step 3 Condensation with pyrimidine sulfone:
  • Method b 1.310 g (4.2 mmol) of imine-reduced product (IV), 0.916 g (4.2 mmol) of pyrimidine sulfone and 1.159 g (8.4 mmol) of anhydrous potassium carbonate in 20 mL of DMF at room temperature for 8-9 h, TLC Control the endpoint of the reaction.
  • WP Wettable powder
  • Mq compound (I-1) (Table 1)
  • JFC lauryl alcohol polyoxyethylene ether
  • Diatomaceous earth 40 % Diatomaceous earth and 44% light calcium carbonate are evenly mixed and crushed to obtain a wettable powder.
  • Example 22 Wettable powder (WP) formula: 15% compound (I-1) (Table 1), 5% lignin sulfonate ( Mq ), 1% lauryl alcohol polyoxyethylene ether (JFC), 40 % Diatomaceous earth and 44% light calcium carbonate are evenly mixed and crushed to obtain a wettable powder.
  • Granule (GR) formulation 5% compound (I-1) (Table 1), 1% polyvinyl alcohol (PVA), 4% sodium naphthalenesulfonate formaldehyde condensate (NMO) and 90% clay are uniform It was mixed and pulverized, and then 20 parts of water was added to the 100 parts of the mixture, kneaded, and granulated by an extruder to obtain 14-32 mesh granules, and dried to obtain 5% granules.
  • Example 24 5% compound (I-1) (Table 1), 1% polyvinyl alcohol (PVA), 4% sodium naphthalenesulfonate formaldehyde condensate (NMO) and 90% clay are uniform It was mixed and pulverized, and then 20 parts of water was added to the 100 parts of the mixture, kneaded, and granulated by an extruder to obtain 14-32 mesh granules, and dried to obtain 5% granules.
  • Example 24
  • EW Water emulsion
  • an oil phase and an aqueous phase are respectively prepared, and then the two are mixed under high speed stirring to form 15% water emulsion with good dispersibility.
  • the herbicidal activity evaluation test was performed according to the following methods:
  • the test soil was a prepared sandy loam soil.
  • the diameter of the pot bowl for the herbicidal activity test was 9.5 cm, and the diameter of the pot bowl for the safety test was 12.0 cm.
  • the pre-emergence test pot was sprayed with soil surface one day after sowing.
  • the treated liquid was the compound dissolved with organic solvents such as acetone and DMF, and 0.5% Tween-80 laboratory preparation was added, and then diluted with water as needed. dose.
  • the post-emergence test pot was placed in the greenhouse for 7-9 days after sowing, and then foliar sprayed.
  • the treated liquid was a compound dissolved with organic solvents such as acetone and DMF, and 0.5% Tween-80 was added. Chamber preparation, and diluted with water to the required dose.
  • the compound treatment concentration in the first activity determination test was 300 gai / ha or 150 gai / ha
  • the compound treatment concentration in the second activity determination test was 75, 150, and 300 gai / ha or 37.5, 75, 150 gai / ha.
  • the treated pots were allowed to stand for 1 day, then placed in a greenhouse, and watered regularly. After 14 to 21 days, the herbicidal activity of the recorded compounds was observed visually.
  • the herbicidal activity of the compound was visually measured by the degree of plant damage symptoms (inhibition, malformation, yellowing, albinism). 0 means no herbicidal effect or safety to the crop, and 100% means complete weed or crop killing.
  • 70-80 is more sensitive, it can be considered extremely sensitive, serious drug damage, eliminated
  • the types of weeds and crops selected for the biological activity test are as follows:
  • Echinochloa crusgalli Tendon serrata, rice branch width, purslane number g ai / ha

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The present invention disclosed a series of 2-pyrimidionxy-N-carbamidophenylbenzylamine compounds and processes of the preparation thereof and the herbicide use of the same. The compounds represented by the following formula (I), wherein D or E is hydrogen, halogen, C1-C4 alkyl, C1-C4 akloxy, C1-C4 alkylogen or C1-C4 alkyloxygen, X is hydrogen, halogen, nitro-, cyano-, carboxyl, ester, sulfonyl, C1-C8 alkylamido, C1-C8 alkylamido halide, C1-C8 alkylacyl, C1-C8 alkyl, C1-C8 alkylogen, C1-C8 akloxy, phenyl, benzo-, substituted phenyl or heterocycle; R1R2 is hydrogen, ester, sulfonyl, C1-C8 alkyl, C1-C8 substituted alkyl, C1-C8 alkylacyl, phenyl or heterocycle; X' is H, cabamido, halogen, carboxyl, ester, C1-C8 alkylacyl, C1-C8 alkyl, C1-C8 alkyl halide, C1-C8 akloxy, phenyl, substituted phenyl or heterocycle et al; R3 is hydrogen, C1-C8 alkylacyl, C1-C8 alkylacyl halide, benzoyl, substituted benzoyl, C1-C8 alkyl.

Description

2—嘧啶氧基— N—脲基苯基苄胺类化合物、 制备方法及其用途 技术领域  2-pyrimidinyloxy-N-ureidophenylbenzylamine compound, preparation method and application thereof
本发明涉及一类新的 2—嘧啶氧基一 N—脲基苯基苄胺类化合物、 制备方法及其作 为农用化学除草剂的用途。 背景技术  The present invention relates to a new class of 2-pyrimidinyloxy-N-ureidophenylbenzylamine compounds, a preparation method and uses thereof as agricultural chemical herbicides. Background technique
农药是人类获得粮食, 确保农业稳产、 丰产不可缺少的生产资料, 近百年来, 农药 如杀虫剂、 杀菌剂、 除草剂等为人类作出了巨大的贡献。 近年来, 随着世界人口的不断 增长, 人类对粮食的需要也在不断增加, 但是耕地增长的速度远远跟不上人口增长的速 度, 要解决这个世界性难题, 必须依靠提高单位面积的粮食产量和改善作物品质, 这就 必须采用各种手段, 如育种、 栽培、 施肥等, 而农药的应用也是其中必不可少的手段之 一。 但是, 应该看到的是, 农药在为人类文明作出巨大贡献的同时, 由于认识方面的局 限性, 高毒、 高残留的农药也给人类赖以生存的环境带来了负面影响。 随着社会的进步 和文明的提高, 开发高效、 低毒、 易降解、 安全性和环境相容性好的绿色农药, 以取代 那些低效、 高毒、 高残留及抗性高的传统农药已成为当今新农药创制的方向。  Pesticides are an indispensable means of production for humans to obtain food and ensure stable and high yields in agriculture. In the past century, pesticides such as pesticides, fungicides, and herbicides have made great contributions to mankind. In recent years, with the continuous growth of the world ’s population, humans ’demand for food is also increasing, but the rate of cultivated land growth is far behind the rate of population growth. To solve this worldwide problem, we must rely on increasing the food per unit area. Yield and improvement of crop quality require various means, such as breeding, cultivation, fertilization, and the application of pesticides is also one of the essential means. However, it should be seen that, while pesticides have made great contributions to human civilization, due to cognitive limitations, highly toxic and high-residue pesticides have also negatively affected the environment on which humans depend. With the progress of society and the improvement of civilization, the development of high-efficiency, low-toxicity, easily degradable, safe and environmentally compatible green pesticides has been developed to replace those traditional pesticides with low efficiency, high toxicity, high residue and high resistance. Become the direction of new pesticide creation today.
嘧啶氧基苯类衍生物可以作为化学除草剂已经早有文献报道, 如 Agr. Biol. Chem.,Vol. 30, P896 ( 1966); 日本专利 79— 55729; 美国专利 4,248,619和 4,427,437。, 近来, 在嘧啶氧基苯类衍生物的基础上, 一类具有优异除草活性的化合物一一嘧啶水杨 酸类衍生物被发现,如欧洲专利 223,406、 249,708、 287,072、 287,079、 315,889、 321,846、 330,990、 335,409、 346,789、 363,040、 402,751、 435,170、 435,186、 457,505、 459,243、 468,690、 658,549和 768034;日本专利 04368361;英国专利 2,237,570;德国专利 3,942,476 等。 其中具有代表性的例子有: 嘧草硫醚(Pyrithiobac-sodium, KIH— 2031, 欧洲专利 315889 )、 双草醚 ( Bispyribac-sodium , KIH - 2023 , 欧洲专利 321846 )、 嘧草醚 (Pyriminobac-methyl, KIH— 6127, 日本专利 04368361 )、 嘧啶肟草醚(Pyribenzoxim, 欧洲专利 658549)和环脂草醚(Pyriftalid, 欧洲专利 768034), 它们的作用机制与磺酰 脲类除草剂相同, 均为乙酰乳酸合成酶(ALS ) 的抑制剂, 破坏植物体内氨基酸如缬氨 酸、亮氨酸和异亮氨酸的合成。 虽然嘧啶水杨酸类化合物具有很高的除草活性, 但是目 前仅适用于棉花田和水稻田的除草。  Pyrimidinyloxybenzene derivatives can be used as chemical herbicides, such as Agr. Biol. Chem., Vol. 30, P896 (1966); Japanese patent 79-55729; US patents 4,248,619 and 4,427,437. Recently, on the basis of pyrimidinyloxybenzene derivatives, a class of compounds having excellent herbicidal activity, a pyrimidinesalicylic acid derivative has been discovered, such as European patents 223,406, 249,708, 287,072, 287,079, 315,889, 321,846, 330,990, 335,409, 346,789, 363,040, 402,751, 435,170, 435,186, 457,505, 459,243, 468,690, 658,549, and 768034; Japanese patent 04368361; British patent 2,237,570; German patent 3,942,476, etc. Representative examples include: Pyrithiobac-sodium (KIH-2031, European Patent 315889), Bispyribac-sodium (KIH-2023, European Patent 321846), Pyriminobac-methyl , KIH-6127, Japanese Patent 04368361), Pyribenzoxim (European Patent 658549), and Cyclopsalid (Pyriftalid, European Patent 768034), their mechanism of action is the same as that of sulfonylurea herbicides, all of which are acetyl Inhibitors of lactic acid synthase (ALS) disrupt the synthesis of amino acids such as valine, leucine and isoleucine in plants. Although pyrimidinesalicylic acid compounds have high herbicidal activity, they are currently only applicable to weeding in cotton and rice fields.
1 1
确 认 本 吕龙等人报道了一类新的嘧啶氧基苄基取代芳基胺类衍生物、 制备方法及其作为 农用化学除草剂的应用 (CN 00130735.5和 CN01112689.2)。 但是, 目前我国具有自主 知识产权的新农药品种很有限, 因此, 开发新的农药仍是人们的研究课题。 发明概要 Confirm this Lu Long et al. Reported a new class of pyrimidinyloxy benzyl substituted arylamine derivatives, preparation methods and their applications as agricultural chemical herbicides (CN 00130735.5 and CN01112689.2). However, at present, the number of new pesticides with independent intellectual property rights in China is very limited. Therefore, the development of new pesticides is still a research topic for people. Summary of invention
本发明提供一种新的化合物, 即 2—嘧啶氧基一 N—脲基苯基 胺类化合物, 同时 提供了上述化合物的制备方法和作为农用化学除草剂的用途。 所述的化合物结构式如  The present invention provides a new compound, that is, 2-pyrimidinyloxy-N-ureidophenylamine compounds, and also provides a method for preparing the above compounds and uses as an agricultural chemical herbicide. The compound has the structural formula such as
Figure imgf000004_0001
发明内容
Figure imgf000004_0001
Summary of the invention
本发明要解决的问题是提供一种新的化合物, 即 2—嘧啶氧基一 N—脲基苯基苄胺 类化合物。  The problem to be solved by the present invention is to provide a new compound, that is, a 2-pyrimidinyloxy-N-ureidophenylbenzylamine compound.
本发明还要解决的问题是提供上述化合物的制备方法。  The problem to be solved by the present invention is to provide a method for preparing the aforementioned compound.
本发明要解决的另一问题是提供一种上述化合物的用途。  Another problem to be solved by the present invention is to provide a use of the above compound.
本发明提供了一种 2—嘧啶氧基一 N—脲基苯基苄胺类化合物的结构式如(I)所示:  The invention provides a 2-pyrimidinyloxy-N-ureidophenylbenzylamine compound having the structural formula shown in (I):
Figure imgf000004_0002
Figure imgf000004_0002
(I) 其中-(I) among them-
D和 E可以是相同的或者不同的基团, 分别为氢、 卤素、 Q—C4垸基、 —C4烷 氧基、 Q— C4卤代烷基或 Q— C4卤代垸氧基, 特别可取的是 D和 E两者均为甲氧基。 D and E may be the same or different groups, which are hydrogen, halogen, Q—C 4 fluorenyl, —C 4 alkoxy, Q—C 4 haloalkyl, or Q—C 4 halofluorenyl, It is particularly preferred that both D and E are methoxy.
X为氢、 卤素、 硝基、 氰基、 羧基、 酯基、 磺酰基、 Q— C8垸基、 d—C8卤代垸 基、 d— C8烷氧基、 C厂 C8垸酰基、 d—C8焼酰氨基、 Q— C8卤代烷酰氨基、 苯基、 苯并基、 取代苯基、 杂环基或取代杂环基 等, 推荐 X为 H或甲氧基, X在苯环上可 处于 3、 4、 5、 6位中的任何一个、 二个或多个位置。 X is hydrogen, halogen, nitro, cyano, carboxyl, ester, sulfonyl, Q-C 8 fluorenyl, d-C 8 halofluorenyl, d-C 8 alkoxy, C plant C 8 acyl , D—C 8 amidamido, Q—C 8 haloalkanoyl, phenyl, benzoyl, substituted phenyl, heterocyclyl or substituted heterocyclyl, etc., it is recommended that X be H or methoxy, X be in benzene The ring can be in any one, two, or more of the 3, 4, 5, and 6 positions.
R2  R2
X'为 H、脲基 (H2Nl'NR1, 所述的脲基上的取代基为 和 )、 卤素原子、 羧 X 'is H, ureido (H 2 Nl' N , R1 , the substituents on the ureido are and), halogen atom, carboxyl
0  0
基、 酯基、 d—C8烷基、 Q— C8卤代烷基、 Q— C8垸氧基、 d— C8垸酰基、 苯基、 取 代苯基、杂环基或取代杂环基。 11为 1~4的整数。 X,为苯环上单取代、二取代或多取代。 Group, ester group, d-C 8 alkyl group, Q-C 8 haloalkyl group, Q-C 8 alkoxy group, d-C 8 alkanoyl group, phenyl group, substituted phenyl group, heterocyclic group or substituted heterocyclic group. 11 is an integer from 1 to 4. X is mono-, di- or poly-substituted on the benzene ring.
, 为氢、 酯基、 磺酰基、 —C8烷基、 取代的 d—C8垸基(推荐卤素或 一 C8烷氧基取代的垸基, 可以是单取代、 二取代或多取代, 例如 CH2OC¾、 CH2C1、 CF3等)、 一¾烷氧基、 一¾烷酰基、 苯基、 取代苯基、 杂环基或取代杂环基, 或 者 RhR2相连为 -(CH2)mZ(CH2)k -,其中 Z为 CH2、 NH、 0或 S, m、 k为 1到 6的整数。 推荐 R 为 H, 正丁基或正丁基,正丁基, 或 , 相连为 -(C¾)5-。 R R2是相同或 不同的基团。其中脲基(( )Ν。ΟΝΗ— )可以处于苯环的邻、 间或对位, 也可以在含 有脲基同时含有其它取代基, 如卤素、 羧基、 酯基、 —C8垸基、 — C8卤代垸基、 一¾烷氧基、 d—Cs烷酰基、 苯基、 取代苯基、 杂环基或取代杂环基等。 Is hydrogen, ester, sulfonyl, —C 8 alkyl, substituted d—C 8 fluorenyl (halogen or mono C 8 alkoxy substituted fluorenyl may be mono-, di-, or poly-substituted, For example, CH 2 OC¾, CH 2 C1, CF 3, etc.), monoalkoxy, monoalkanoyl, phenyl, substituted phenyl, heterocyclyl or substituted heterocyclyl, or Rh R 2 is connected as-( CH 2 ) m Z (CH 2 ) k- , where Z is CH 2 , NH, 0 or S, and m and k are integers from 1 to 6. It is recommended that R is H, n-butyl or n-butyl, n-butyl, or, connected to-(C¾) 5-. RR 2 is the same or different group. Wherein the ureido group (() N.ΟΝ —) can be in the ortho, meta or para position of the benzene ring, or it can contain ureido group and other substituents, such as halogen, carboxyl, ester group, —C 8垸 group, — C halogenated alkyl with 8, a ¾-alkoxy, d-C s alkyl group, a phenyl group, a substituted phenyl group, a heterocyclic group or substituted heterocyclic group.
R3=氢、 d—C8垸酰基、 d—C8卤代烷酰基、 苯甲酰基、 取代笨甲酰基、 d—C8 焼基。 R 3 = hydrogen, d-C 8 amidino, d-C 8 haloalkanoyl, benzoyl, substituted benzoyl, d-C 8 amidino.
其中所述的杂环基如吡啶基、 噻吩基、 噻唑基、 嘧啶基等, 所述的取代苯基、 取代 杂环基或取代苯甲酰基上的取代基推荐为卤素、 硝基、 氰基、 羧基、 酯基、磺酰基、 d —C8烷基、 d— C8卤代綜基、 d— 垸氧基、 C厂 C8烷酰基或 C广 C8烷酰氨基等; 所 述的取代苯基、 取代杂环基或取代苯甲酰基推荐为单取代、 二取代或多取代的。 推荐的本发明的化合物具有如下结构通式: Wherein the heterocyclic group such as pyridyl, thienyl, thiazolyl, pyrimidinyl, etc., the substituted phenyl, substituted heterocyclic group or substituted benzoyl group is preferably halogen, nitro, cyano , a carboxyl group, an ester group, a sulfonyl group, d -C 8 alkyl, d- C mechanized. 8 haloalkyl group, d- embankment group, C factory wide. 8 C C C alkanoyl or alkanoylamino group and the like. 8; the Substituted phenyl, substituted heterocyclyl or substituted benzoyl are recommended as mono-, di- or poly-substituted. The recommended compounds of the present invention have the following structural formula:
Figure imgf000006_0001
Figure imgf000006_0001
下面, 我们将本发明的一些典型化合物列于表 Below, we list some typical compounds of the present invention in the table.
表一  Table I
Figure imgf000006_0002
Figure imgf000006_0002
化合 D E X (R!R2)NC Ri R2 R3 (X')n 物编 ONH-的 Compound DEX (R! R 2 ) NC Ri R 2 R 3 (X ') n Material ONH-
号 位置  Location
1- 1 OMe OMe H 对位 Et Et H H 1- 1 OMe OMe H Para Et Et H H
1—2 OMe OMe H 间位 Et Et H H1-2 OMe OMe H meta Et Et H H
1—3 OMe OMe 6-C1 间位 Et Et H H1-3 OMe OMe 6-C1 meta Et Et H H
1-4 OMe OMe 6-OMe 间位 Et Et H H1-4 OMe OMe 6-OMe meta Et Et H H
1—5 OMe OMe H 间位 nPr "Pr H H1—5 OMe OMe H meta n Pr "Pr HH
1-6 OMe OMe 6-C1 间位 nPr nPr H H1-6 OMe OMe 6-C1 meta n Pr n Pr HH
1-7 OMe OMe 6-MeO 间位 nPr nPr H H1-7 OMe OMe 6-MeO meta n Pr n Pr HH
1-8 OMe OMe H 对位 nBu "Bu H H1-8 OMe OMe H Para n Bu "Bu HH
1-9 OMe OMe H 间位 nBu "Bu H H- 10 OMe OMe 6-C1 间位 nBu nBu H H- 11 OMe OMe 6-MeO 间位 nBu nBu H H- 12 OMe OMe H 对位 (CH2)5 (CH2)5 H H - 13 OMe OMe H 对位 Ij^^ OEt H H H - 14 OMe OMe H 对位 H H H 1-9 OMe OMe H meta n Bu "Bu H H- 10 OMe OMe 6-C1 meta n Bu n Bu H H- 11 OMe OMe 6-MeO meta n Bu n Bu H H- 12 OMe OMe H pair Bit (CH 2 ) 5 (CH 2 ) 5 HH -13 OMe OMe H paraposition Ij ^^ OEt HHH-14 OMe OMe H paraposition HHH
Me Me
- 15 OMe OMe H 对位 H H H - 16 OMe OMe H 间位 H H H - 17 OMe OMe H 对位 H H H - 18 OMe OMe H 间位 H H H - 19 OMe OMe 6-OMe 间位 H H H -20 OMe OMe 6-F 间位 nBu nBu H H-21 CI OMe H 3-位 COOMe CF3 CH3CO 4- CI-22 Me OMe COOH 3-位 H MeO CICH2CO 5-NHCONH2-23 CI Me H 3-位 H COOMe Me 5-OMe 其中 Me代表甲基, Et代表乙基, nPr代表正丙基, nBu代表正丁基。 本发明所涉及的化合物 2—嘧啶氧基一 N—脲基苯基苄胺类化合物可以用如下的反 应步骤合成: -15 OMe OMe H para HHH-16 OMe OMe H meta HHH-17 OMe OMe H para HHH-18 OMe OMe H meta HHH-19 OMe OMe 6-OMe meta HHH -20 OMe OMe 6-F Bit n Bu n Bu H H-21 CI OMe H 3-position COOMe CF 3 CH 3 CO 4- CI-22 Me OMe COOH 3-position H MeO CICH2CO 5-NHCONH 2 -23 CI Me H 3-position H COOMe Me 5-OMe where Me represents methyl, Et represents ethyl, n Pr represents n-propyl, and n Bu represents n-butyl. The compound 2-pyrimidinyloxy-N-ureidophenylbenzylamine compounds related to the present invention can be synthesized by the following reaction steps:
Figure imgf000007_0001
. 上述反应式中的 , R2、 X、 X'、 n以及 D, E所代表的取代基如前所述, Y为卤 素或甲砜基。 反应中的起始原料(II) 可以通过下列反应制备:
Figure imgf000007_0001
In the above reaction formula, the substituents represented by R 2 , X, X ′, n, D, and E are as described above, and Y is halogen or methylsulfone. The starting material (II) in the reaction can be prepared by the following reaction:
Figure imgf000008_0001
Figure imgf000008_0001
(11-3)  (11-3)
式中 R为卤素、 硝基、 氰基、 羧基、 酯基、 磺酰基、 —C8烷基、 — C8卤代烷 基、 。广^烷氧基、 Q_C8烷酰基或 —C8垸酰氨基等。 中间体 (Π -1 ) 合成可以通 过还原硝基苯基脲制备, 可以在催化剂的作用下用氢气还原取代硝基苯基脲制得, 催化 剂可以是雷式镍 (Raney Ni)、 钯碳或铂黑等, 取代硝基苯胺、 氢与催化剂的摩尔比推 荐为 1 : (1— 1000): (0.01 -0.5), 使用更多的氢气对反应没有影响。 反应温度推荐为室 温至摄氏 40度, .反应时间推荐为 0.5至 10小时, 推荐的溶剂可以为苯、 甲苯或二甲苯等 烃类溶剂; 四氢呋喃或二氧六环等醚类溶剂; 甲醇, 乙醇或异丙醇等醇类溶剂; 也可以用 二甲基甲酰胺、二甲亚砜、 乙腈以及上述溶剂的混合物,该反应的溶剂进一步推荐为醇类。 该中间体(II- 1 )也可以在催化剂的作用下用水合肼还原取代硝基苯基脲制得, 催化剂可 以是雷式镍 (Raney Ni) 等, 取代硝基苯胺、 水合肼与催化剂的摩尔比推荐为 1 : (1 - 1.5): (0.01— 0.5), 使用更多的水合肼对反应没有影响。 反应温度推荐为室温至摄氏 40度, 反应时间推荐为 0.5至 10小时, 推荐的溶剂可以为苯、 甲苯或二甲苯等烃类溶 剂; 四氢呋喃或二氧六环等醚类溶剂; 甲醇, 乙醇或异丙醇等醇类溶剂; 也可以用二甲 基甲酰胺、 二甲亚砜、 乙腈以及上述溶剂的混合物, 该反应的溶剂进一步推荐为醇类。 硝基苯基脲合成可以通过硝基苯异氰酸酯与取代脂肪胺反应制备, 摩尔比推荐为 1 : 1 至 1 : 2。推荐的溶剂可以为苯、 甲苯或二甲苯等烃类溶剂; 四氢呋喃或二氧六环等醚类 溶剂; 该反应的溶剂进一步推荐为苯。 反应温度推荐为 5°C至室温, 反应时间推荐为 0.5到 12小时。 中间体(Π -2)合成可以通过还原硝基苯基取代芳基脲制备, 还原条件 可以与中间体(Π -1 )合成相同, 硝基苯基取代芳基合成可以通过硝基苯胺与取代芳香 异氰酸酯反应制备, 摩尔比推荐为 1 : 1至 1 : 1.5。 推荐的溶剂可以为苯、 甲苯或二甲 苯等烃类溶剂;四氢呋喃或二氧六环等醚类溶剂;该反应的溶剂进一步推荐为四氢呋喃。 反应温度推荐为室温至回流, 反应时间推荐为 8到 48小时。 中间体 (Π -3 ) 合成可以 通过还原对硝基苯基脂肪基脲制备, 还原条件可以与中间体(Π -1 )合成相同, 对硝基 苯基脂肪基脲合成可以通过以下的方法来合成: 将对硝基苯胺溶解在热的冰乙酸中, 加 入氰酸钠, 摩尔比推荐 1 : 1至 1 : 5, 过滤得对硝基苯脲。 将对硝基苯脲在二丁胺或六 氢吡啶中回流得对硝基苯基脂肪基脲。 此外, 苯环上含有 (X')n取代基的起始原料 (II)的 合成方法与上述反应方法相同。 In the formula, R is halogen, nitro, cyano, carboxyl, ester, sulfonyl, —C 8 alkyl, —C 8 haloalkyl,. Broad alkoxy, Q_C 8 alkanoyl, or -C 8 amidamido and the like. Intermediate (Π -1) synthesis can be prepared by reducing nitrophenyl urea. It can be prepared by reducing nitrophenyl urea with hydrogen under the action of a catalyst. The catalyst can be Raney Ni, palladium carbon or For platinum black, etc., the molar ratio of substituted nitroaniline, hydrogen and catalyst is recommended to be 1: (1—1000): (0.01 -0.5). Using more hydrogen has no effect on the reaction. The reaction temperature is recommended from room temperature to 40 ° C. The reaction time is recommended from 0.5 to 10 hours. The recommended solvents can be hydrocarbon solvents such as benzene, toluene or xylene; ether solvents such as tetrahydrofuran or dioxane; methanol, ethanol Or an alcohol solvent such as isopropyl alcohol; dimethylformamide, dimethylsulfoxide, acetonitrile, and a mixture of the above solvents can also be used, and the solvent of the reaction is more preferably an alcohol. The intermediate (II-1) can also be prepared by reducing and replacing nitrophenylurea with hydrazine hydrate under the action of a catalyst. The catalyst may be Raney Ni, etc., which replaces nitroaniline, hydrazine hydrate and the catalyst. The molar ratio is recommended to be 1: (1 -1.5): (0.01-0.5), using more hydrazine hydrate has no effect on the reaction. The reaction temperature is recommended to be room temperature to 40 ° C, and the reaction time is recommended to be 0.5 to 10 hours. The recommended solvents can be hydrocarbon solvents such as benzene, toluene or xylene; ether solvents such as tetrahydrofuran or dioxane; methanol, ethanol or Alcohol solvents such as isopropyl alcohol; dimethylformamide, dimethyl sulfoxide, acetonitrile, and a mixture of the above solvents can also be used. The solvent for this reaction is further recommended as an alcohol. Nitrophenyl urea synthesis can be prepared by reacting nitrophenyl isocyanate with a substituted fatty amine, and the molar ratio is recommended to be 1: 1 to 1: 2. The recommended solvent may be a hydrocarbon solvent such as benzene, toluene or xylene; an ether solvent such as tetrahydrofuran or dioxane; and the solvent for the reaction is further recommended as benzene. The reaction temperature is preferably 5 ° C to room temperature, and the reaction time is preferably 0.5 to 12 hours. Intermediate (Π-2) synthesis can be prepared by reducing nitrophenyl to replace aryl urea. Reduction conditions can be the same as those of intermediate (Π-1) synthesis. Nitrophenyl substituted aryl synthesis can be performed by nitroaniline and substitution. Aromatic isocyanate is prepared by reaction, and the molar ratio is recommended to be 1: 1 to 1: 1.5. The recommended solvent may be a hydrocarbon solvent such as benzene, toluene, or xylene; an ether solvent such as tetrahydrofuran or dioxane; and the solvent for this reaction is further recommended as tetrahydrofuran. The reaction temperature is preferably from room temperature to reflux, and the reaction time is preferably from 8 to 48 hours. Intermediate (Π-3) synthesis can be prepared by reducing p-nitrophenyl fatty urea, and the reduction conditions can be the same as those of intermediate (Π-1). The synthesis of p-nitrophenyl fatty urea can be performed by the following method Synthesis: Dissolve p-nitroaniline in hot glacial acetic acid, add sodium cyanate, the recommended molar ratio is 1: 1 to 1: 5, and filter to obtain p-nitrophenylurea. The p-nitrophenyl urea is refluxed in dibutylamine or hexahydropyridine to obtain p-nitrophenyl fatty urea. The method for synthesizing the starting material (II) containing a (X ′) n substituent on the benzene ring is the same as the above-mentioned reaction method.
中间体(III) 的合成可以通过脲基取代苯胺 (Π) 与水杨醛或取代水杨醛反应制备, 摩尔比推荐为 1:0.8〜2, 进一步推荐为 1:1至 1 :2。 推荐的溶剂可以为苯、 甲苯或二甲苯等 烃类溶剂; 二氯甲烷、 二氯乙垸或氯仿等卤代烃溶剂; 四氢呋喃或二氧六环等醚类溶剂; 丙酮或甲基异丁基酮等酮类溶剂; 甲醇、 乙醇或异丙醇等醇类溶剂; 也可以用二甲基甲酰 胺、 二甲亚砜、 乙腈以及上述溶剂的混合物, 该反应的溶剂进一步推荐为醇类。 反应温度 推荐为室温至溶剂沸点, 反应时间推荐为 0.5到 12小时。反应可以在无催化剂的情况下进 行, 加入催化剂有时可以加快反应速度和提高反应收率, 反应中所用的催化剂可以是对甲 基苯磺酸、 甲磺酸、 硫酸、 盐酸或醋酸等, (Π)与催化剂的摩尔比推荐为 1:0.01— 1。  The intermediate (III) can be synthesized by reacting ureido-substituted aniline (Π) with salicylaldehyde or substituted salicylaldehyde. The molar ratio is recommended to be 1: 0.8 ~ 2, and further recommended to be 1: 1 to 1: 2. Recommended solvents can be hydrocarbon solvents such as benzene, toluene or xylene; halogenated hydrocarbon solvents such as dichloromethane, dichloroacetamidine, or chloroform; ether solvents such as tetrahydrofuran or dioxane; acetone or methyl isobutyl Ketone solvents such as ketones; alcohol solvents such as methanol, ethanol, or isopropanol; dimethylformamide, dimethyl sulfoxide, acetonitrile, and mixtures of the above solvents can also be used, and the solvents for this reaction are further recommended as alcohols. The reaction temperature is preferably from room temperature to the boiling point of the solvent, and the reaction time is preferably from 0.5 to 12 hours. The reaction can be performed without a catalyst. The addition of a catalyst can sometimes speed up the reaction speed and increase the reaction yield. The catalyst used in the reaction can be p-toluenesulfonic acid, methanesulfonic acid, sulfuric acid, hydrochloric acid or acetic acid, etc. (Π The molar ratio of) to catalyst is recommended to be 1: 0.01-1.
中间体(IV) 的合成可以通过还原化合物 (III)制得, 还原剂推荐为硼氢化钠或硼氢 化钾,反应物(III)与还原剂的摩尔比推荐为 1:0.5—2, 反应温度推荐为室温至摄氏 40度, 反应时间推荐为 0.5至 10小时, 推荐的溶剂可以为苯、 甲苯或二甲苯等烃类溶剂; 四氯呋 喃或二氧六环等醚类溶剂; 甲醇, 乙醇或异丙醇等醇类溶剂; 也可以用二甲基甲酰 - 胺、 二甲亚砜、 乙腈以及上述溶剂的混合物, 该反应的溶剂进一步推荐为醇类。 另外, 该中间体(IV)也可以在催化剂的作用下用氢气还原化合物(III)制得, 催化剂推荐是 雷式镍 (Raney Ni)、 钯碳或铂黑等, 反应物 (ΠΙ)、 氢与催化剂的摩尔比推荐为 1 :1一 1000:0.01 -0.5, 使用更多的氢气对反应没有影响。 反应温度推荐为室温至摄氏 40度, 反应时间推荐为 0.5至 10小时, 推荐的溶剂可以为苯、 甲苯或二甲苯等烃类溶剂; 四氢 呋喃或二氧六环等醚类溶剂; 甲醇, 乙醇或异丙醇等醇类溶剂;也可以用二甲基甲酰胺、 二甲亚砜、 乙腈以及上述溶剂的混合物, 该反应的溶剂进一步推荐为醇类。 The intermediate (IV) can be synthesized by reducing compound (III). The reducing agent is recommended to be sodium borohydride or potassium borohydride. The molar ratio of reactant (III) to reducing agent is recommended to be 1: 0.5-2. The reaction temperature Recommended room temperature to 40 degrees Celsius, reaction time recommended 0.5 to 10 hours, recommended solvents can be hydrocarbon solvents such as benzene, toluene or xylene; ether solvents such as tetrachlorofuran or dioxane; methanol, ethanol or Alcohol solvents such as isopropanol; dimethylformyl- A mixture of amine, dimethyl sulfoxide, acetonitrile, and the above-mentioned solvents, and the solvent of the reaction is more preferably an alcohol. In addition, the intermediate (IV) can also be prepared by reducing the compound (III) with hydrogen under the action of a catalyst. The catalyst is recommended to be Raney Ni, palladium carbon, platinum black, etc., the reactant (II), hydrogen The molar ratio to the catalyst is recommended to be 1: 1 to 1000: 0.01 -0.5. Using more hydrogen has no effect on the reaction. The reaction temperature is recommended to be room temperature to 40 ° C, and the reaction time is recommended to be 0.5 to 10 hours. The recommended solvents can be hydrocarbon solvents such as benzene, toluene or xylene; ether solvents such as tetrahydrofuran or dioxane; methanol, ethanol or Alcohol solvents such as isopropyl alcohol; dimethylformamide, dimethyl sulfoxide, acetonitrile, and a mixture of the above solvents can also be used. The solvent for this reaction is more preferably an alcohol.
最后, 将中间体(IV)与 2-卤代 -4-D,6-E-取代嘧啶或 2-甲砜基 -4-D,6-E-取代嘧啶在 碱的存在下反应制得目标产物(I) (R3=H), 在该步反应中, 所用碱推荐是一价或二价 金属的氢化物、 烷氧金属化合物或其碳酸盐, 如氢化钠、 氢化钾、 氢化钙; 甲醇钠或乙 醇钠、 甲醇钾或乙醇钾; 碳酸钠、碳酸钾或碳酸钙等, 也可以是三乙胺、吡啶等有机碱。 推荐的反应溶剂可以为苯、 甲苯或二甲苯等烃类溶剂; 二氯甲烷、 二氯乙垸或氯仿等卤 代烃溶剂; 四氢呋喃或二氧六环等醚类溶剂; 丙酮或甲基异丁基酮等酮类溶剂; 甲醇, 乙醇或异丙醇等醇类溶剂; 也可以用二甲基甲酰胺、 二甲亚砜、 乙腈以及上述溶剂的混 合物,该反应的最佳溶剂为醚类。反应温度推荐为室温至溶剂沸点,反应时间推荐为 0.5 到 20小时。 中间体 (IV)、 2-卤代 -4-D,6-E-取代嘧啶或 2-甲砜基 -4-D,6-E-取代嘧啶和碱 的摩尔比推荐为 1 : 1.0— 1.2 : 1— 5 。 最终产物可经硅胶柱层析或重结晶进一步纯化。 Finally, the intermediate (IV) is reacted with 2-halo-4-D, 6-E-substituted pyrimidine or 2-methylsulfo-4-D, 6-E-substituted pyrimidine in the presence of a base to obtain the target. Product (I) (R 3 = H). In this step, it is recommended that the base used is a hydride of a monovalent or divalent metal, an alkoxy metal compound or a carbonate thereof, such as sodium hydride, potassium hydride, calcium hydride ; Sodium methoxide or sodium ethoxide, potassium methoxide or potassium ethoxide; sodium carbonate, potassium carbonate, or calcium carbonate, etc .; or an organic base such as triethylamine, pyridine, or the like. Recommended reaction solvents can be hydrocarbon solvents such as benzene, toluene or xylene; halogenated hydrocarbon solvents such as dichloromethane, dichloroacetamidine or chloroform; ether solvents such as tetrahydrofuran or dioxane; acetone or methyl isobutyl Ketone solvents such as methyl ketone; alcohol solvents such as methanol, ethanol, or isopropanol; dimethylformamide, dimethylsulfoxide, acetonitrile, and mixtures of the above solvents can also be used. The best solvent for this reaction is ethers. The reaction temperature is preferably from room temperature to the boiling point of the solvent, and the reaction time is preferably from 0.5 to 20 hours. The molar ratio of intermediate (IV), 2-halo-4-D, 6-E-substituted pyrimidine or 2-methylsulfonyl-4-D, 6-E-substituted pyrimidine to base is recommended to be 1.0: 1.2 : 1-5. The final product can be further purified by silica gel column chromatography or recrystallization.
目标产物 (I) (R3=H) 与酰氯或卤代垸 R3C1 (R3≠H)在溶剂中并在碱存在下反应 得到目标产物 (I) (R3≠H), 反应温度在室温到溶剂沸点温度, 其中溶剂和碱如前所述。 The target product (I) (R 3 = H) is reacted with an acid chloride or a halogenated hafnium R 3 C1 (R 3 ≠ H) in a solvent and in the presence of a base to obtain the target product (I) (R 3 ≠ H) at a reaction temperature At room temperature to the boiling point of the solvent, the solvent and base are as previously described.
除非另外说明, 本发明所述的烷基、 取代垸基、 烷氧基、 卤代垸基、 卤代垸氧基、 酯基、烷酰基、烷酰胺基、 卤代烷酰胺基均指直链或支链的基团,推荐为 1到 8碳数的, 进一步推荐为 1到 4碳数的。  Unless otherwise stated, the alkyl, substituted fluorenyl, alkoxy, halofluorenyl, halofluorenyl, ester, alkanoyl, alkylamide, and haloalkylamide groups in the present invention refer to straight or branched chain. The chain group is preferably 1 to 8 carbons, and further preferably 1 to 4 carbons.
除非另外说明, 本发明中提到的酯基, 推荐为 1到 8碳数的烷氧羰基、 苯氧羰基或 取代苯氧羰基, 进一步推荐为 1到 4碳数的烷氧羰基、 苯氧羰基或取代苯氧羰基; 本发 明中提到的的磺酰基,推荐为 1到 8碳数.的烷基磺酰基、苯基磺酰基或取代苯基磺酰基, 进一步推荐为 1到 4碳数的烷基磺酰基、苯基磺酰基或取代苯基磺酰基; 所述的取代苯 氧羰基或取代苯基磺酰基上推荐是单取代、 二取代或多取代的, 取代基推荐为卤素、 硝 基、 氰基、 羧基、 酯基、 磺酰基、 — 垸基、 d _C8卤代垸基、 d—C8垸氧基、 d 一 C8烷酰基或 — C8烷酰氨基等。 本发明提供了上述 2—嘧啶氧基一 N—脲基苯基苄胺类化合物的用途, 即可以用于 除草剂。 Unless otherwise stated, the ester group mentioned in the present invention is preferably an alkoxycarbonyl group, a phenoxycarbonyl group or a substituted phenoxycarbonyl group with a carbon number of 1 to 8, and further an alkoxycarbonyl group, a phenoxycarbonyl group with a carbon number of 1 to 4 Or substituted phenoxycarbonyl group; the sulfonyl group mentioned in the present invention is recommended to be an alkylsulfonyl group, a phenylsulfonyl group or a substituted phenylsulfonyl group, and further recommended to be a carbon number of 1 to 4 Alkylsulfonyl, phenylsulfonyl or substituted phenylsulfonyl; The substituted phenoxycarbonyl or substituted phenylsulfonyl is recommended to be mono-, di- or poly-substituted, and the substituents are preferably halogen, nitro , a cyano group, a carboxyl group, an ester group, a sulfonyl group, - alkyl with, d _C 8 alkyl with halo, d-C 8 alkoxy embankment, d alkanoyl or a C 8 - C 8 alkanoylamino group. The invention provides the use of the aforementioned 2-pyrimidinyloxy-N-ureidophenylbenzylamine compound, that is, it can be used as a herbicide.
以本发明的化合物作为农药化学除草剂的活性组份, 配制成各种液剂、 乳油、 悬浮 剂、 水悬剂、 微乳剂、 (水)乳剂、 粉剂、 可湿性粉剂、 可溶性粉剂、 (水分散性)颗 粒剂或胶囊剂等,可以用于水稻、 大豆、 小麦、 棉花、 玉米和油菜等农作物的杂草防治。  The compound of the present invention is used as an active ingredient of a pesticide chemical herbicide, and is formulated into various liquids, emulsifiable concentrates, suspensions, suspensions, microemulsions, (water) emulsions, powders, wettable powders, soluble powders, (water Dispersible) granules or capsules can be used for weed control in crops such as rice, soybean, wheat, cotton, corn and rape.
制剂中活性组分的重量百分含量推荐为 5~90%, 其余为载体,载体至少包括两种, 其 中至少一种是表面活性剂。载体可以是固体或液体。合适的固体载体包括天然的或合成的 粘土和硅酸盐,例如天然硅石和硅藻土;硅酸镁例如滑石;硅酸铝镁例如高岭石、高岭土、 蒙脱土和云母; 白碳黑、碳酸钙、轻质碳酸钙; 硫酸钙; 石灰石; 硫酸钠; 胺盐如硫酸铵、 六甲撑二胺。液体载体包括水和有机溶剂, 当用水做溶剂或稀释剂时, 有机溶剂也能用做 辅助剂或防冻添加剂。合适的有机溶剂包括芳烃例如苯、二甲苯、 甲苯等; 氯代经, 例如 氯代苯、氯乙烯、三氯甲烷、二氯甲垸等; 脂肪烃, 例如石油馏分、环己烷、轻质矿物油; 醇类, 例如异丙醇、 丁醇、 乙二醇、 丙三醇和环己醇等; 以及它们的醚和酯; 还有酮类, 例如丙酮、环己酮以及二甲基甲酰胺和 N-甲基-吡咯烷酮。  The weight percentage of the active ingredient in the preparation is recommended to be 5 to 90%, and the rest are carriers. The carrier includes at least two kinds, at least one of which is a surfactant. The carrier can be a solid or a liquid. Suitable solid carriers include natural or synthetic clays and silicates such as natural silica and diatomaceous earth; magnesium silicates such as talc; magnesium aluminum silicates such as kaolinite, kaolin, montmorillonite, and mica; white carbon black , Calcium carbonate, light calcium carbonate; calcium sulfate; limestone; sodium sulfate; amine salts such as ammonium sulfate, hexamethylene diamine. Liquid carriers include water and organic solvents. When water is used as a solvent or diluent, organic solvents can also be used as adjuvants or antifreeze additives. Suitable organic solvents include aromatic hydrocarbons such as benzene, xylene, toluene, etc .; chlorinated compounds such as chlorobenzene, vinyl chloride, chloroform, dichloromethane, etc .; aliphatic hydrocarbons such as petroleum fractions, cyclohexane, light weight Mineral oils; alcohols such as isopropanol, butanol, ethylene glycol, glycerol and cyclohexanol; and their ethers and esters; and ketones such as acetone, cyclohexanone, and dimethylformamide And N-methyl-pyrrolidone.
表面活性剂可以是乳化剂、 分散剂或湿润剂; 可以是离子型的或非离子型的。 非离 子型乳化剂例如聚氧乙烯脂肪酸脂、 聚氧乙烯脂肪醇醚、 聚氧乙烯脂肪氨, 以及市售的 乳化剂: 农乳 2201B、 农乳 0203B、 农乳 100#、 农乳 500#、 农乳 600#、 农乳 600- 2#、 农 乳 1601、农乳 2201、农乳 NP-10、农乳 NP-15、农乳 507#、农乳 OX-635、农乳 OX-622、 农乳 OX-653、 农乳 OX-667、 宁乳 36#。 分散剂包括木质素磺酸钠、 拉开粉、'木质素磺 酸钙、 甲基萘磺酸甲醒缩合物等。 湿润剂为: 月桂醇硫酸钠、 十二垸基苯磺酸钠、 烷基 萘磺酸钠等。 Surfactants can be emulsifiers, dispersants or wetting agents; they can be ionic or non-ionic. Non-ionic emulsifiers such as polyoxyethylene fatty acid esters, polyoxyethylene fatty alcohol ethers, polyoxyethylene fatty ammonia, and commercially available emulsifiers: agricultural milk 2201B, agricultural milk 0203B, agricultural milk 100 # , agricultural milk 500 # , Agricultural milk 600 # , Agricultural milk 600-2 # , Agricultural milk 1601, Agricultural milk 2201, Agricultural milk NP-10, Agricultural milk NP-15, Agricultural milk 507 # , Agricultural milk OX-635, Agricultural milk OX-622, Agricultural Milk OX-653, agricultural milk OX-667, Ning Ru 36 # . Dispersants include sodium ligninsulfonate, pulverized powder, calcium ligninsulfonate, methylnaphthalenesulfonic acid methyl ester condensate, and the like. Wetting agents are: sodium lauryl sulfate, sodium dodecylbenzenesulfonate, sodium alkylnaphthalenesulfonate, and the like.
这些制剂可由通用的方法制备。 例如, 将活性物质与液体溶剂和 /或固体载体混合, 同时加入表面活性剂如乳化剂、 分散剂、 稳定剂、 湿润剂, 还可以加入其它助剂如: 粘 合剂、 消泡剂、 氧化剂等。  These preparations can be prepared by a general method. For example, the active substance is mixed with a liquid solvent and / or a solid carrier, and a surfactant such as an emulsifier, a dispersant, a stabilizer, a wetting agent is also added, and other auxiliary agents such as a binder, an antifoaming agent, and an oxidizing agent may be added. Wait.
本发明的除草活性化合物可以与杀虫剂、 杀菌剂、 杀线虫剂、 植物生长调节剂、 肥 料, 以及其它除草剂或其它农用化学品混配使用。 本发明的化合物及其制剂, 具有以下一些特点和优点:  The herbicidally active compound of the present invention can be mixed with pesticides, fungicides, nematicides, plant growth regulators, fertilizers, and other herbicides or other agricultural chemicals. The compound of the present invention and its preparation have the following characteristics and advantages:
1、 具有高效的除草活性, 在 30~75gai/ha低剂量下表现出较好的芽后除草效果, 在 75~150gai/ha稍高剂量下表现出较好的芽前除草效果。  1. It has effective herbicidal activity, and shows good post-emergent herbicidal effect at low doses of 30 to 75 gai / ha, and good pre-emergent herbicidal effect at slightly higher doses of 75 to 150 gai / ha.
2、 杀草谱较广, 不仅能有效防除农田中禾本科杂草, 而且能防除阔叶杂草和莎草。 3、 具有较好的选择性, 对某些作物安全, 如: 小麦、 大豆、 棉花、 水稻等。 2. A broad spectrum of weed control, which can not only effectively control grass weeds in farmland, but also broad-leaved weeds and sedges. 3. It has good selectivity and is safe for certain crops, such as: wheat, soybean, cotton, rice, etc.
4、 对大龄敏感杂草也具有十分有效的除草活性。  4. It also has very effective herbicidal activity against older sensitive weeds.
5、 在土壤中残留期短, 对后茬作物生长无不良影响。  5. The residual period in the soil is short, and it has no adverse effect on the growth of subsequent crops.
6、 具有合理的毒性、 生态毒性和环境相容性, 属低毒环境友好型农药。  6. It has reasonable toxicity, ecotoxicity and environmental compatibility, and is a low-toxic environment-friendly pesticide.
本发明所提供的结构式为 (I)的化合物, 不仅合成方法简便, 而且具有除草活性和 作物选择性, 能用于除草剂。其制剂能有效地防治大多数农田杂草, 较低剂量下有效 防治敏感的禾本科、阔叶杂草和莎草, crusgalU 马唐 (J igitaria sanguinalis)、 牛筋草 (E
Figure imgf000012_0001
) 早熟禾 {Poa annua) ^ 野燕麦 ( wfir fatua 、 ¾" ¾ ¾ Alopecurus aequalis) 日本看麦娘 {Alopecurus japonicus)、
Figure imgf000012_0002
The compound of formula (I) provided by the present invention has not only a simple synthetic method, but also herbicidal activity and crop selectivity, and can be used as a herbicide. Its preparation can effectively control most farmland weeds, and it can effectively control sensitive grasses, broad-leaved weeds, and sedges at lower doses. CrusgalU J igitaria sanguinalis, goose grass (E
Figure imgf000012_0001
) Poa annua (Poa annua) ^ Wild oats (wfir fatua, ¾ "¾ ¾ Alopecurus aequalis) Japan watch Mai Niang (Alopecurus japonicus),
Figure imgf000012_0002
暴 (Chenopodium albu 、 ^^{Br as sic a juncea)^ 马齿 (portulaca okracea)、 铁觅菜 (Acalypha australis)、 异型莎草 (Qyer s difformis)^ 千金子 (LeptocMoa chinemis)、 香 附子 (Operas rotundus~)、 曰照飘浮草 ( m jr z fc miliaced)、 繁缕 (βίαΙΙατία media) ^ 雀舌草 (Stellaria alsine)、一年蓬 (Erigeron annuus)、矮慈燕 (Sagittaria sagittifolia) 、 田旋花 ( Convolvulus arvensis ) 等。 具体实施方式 Chenopodium albu, ^^ (Br as sic a juncea) ^ portulaca okracea, Acalypha australis, Qyer s difformis ^ LeptocMoa chinemis, Operas rotundus ~), mjr z fc miliaced, stellaria (βίαΙΙατία media) ^ Stellaria alsine, Erigeron annuus, Sagittaria sagittifolia, field swirling flower (Convolvulus arvensis) and so on. detailed description
以下实施例有助于理解本发明, 但本发明并不仅仅局限在下述实施例的范围内。 其中以本发明的化合物作为活性物质组份, 加工配制几种除草剂剂型的实施例中, 所有的 "% "均指重量百分比, "g ai/ha"均指每克活性物 /公顷。 实施例 1  The following examples are helpful for understanding the present invention, but the present invention is not limited to the scope of the following examples. In the embodiment where the compound of the present invention is used as an active material component to process several herbicide formulations, all "%" means weight percentages, and "g ai / ha" means per gram of active matter / ha. Example 1
1、 中间体 (II )合成  1. Synthesis of intermediate (II)
(a) 中间体 (II- 1 ) 的合成  (a) Synthesis of intermediate (II- 1)
第一步: 以 1-对硝基苯基 -3-二乙基脲的合成为例: 在氩气保护下, 在 100 mL带有 温度计和滴液漏斗的三口烧瓶加入加入 0.82克 (5 mmol)对硝基苯基异氰酸酯和 5 mL 无水苯, 0.57 mL (5.5 mmol) 二乙胺溶解在 5 mL无水苯, 冷却至 0-10°C, 滴加到反 应液中, 加完后搅拌约 30min, 旋干, 柱层析得纯品, 收率 98%。  Step 1: Take the synthesis of 1-p-nitrophenyl-3-diethylurea as an example: Under the protection of argon, add a 0.8 mL (5 mmol) to a 100 mL three-necked flask with a thermometer and a dropping funnel. ) P-nitrophenyl isocyanate and 5 mL of anhydrous benzene, 0.57 mL (5.5 mmol) of diethylamine dissolved in 5 mL of anhydrous benzene, cooled to 0-10 ° C, added dropwise to the reaction solution, and stirred after the addition About 30min, spin-dried and purified by column chromatography with a yield of 98%.
第二步: 硝基还原: 将 5 mmoll-对硝基苯基 -3-二乙基脲溶解在 20 mL无水甲醇中, 加入 90mg Raney Ni, 将 0.469克(7.5 mmol)的 80%的水合肼滴加到反应液中, 在室温 下搅拌至反应完全, TLC控制反应终点。过滤后, 滤液旋干得 1.035克 1-对氨基苯基 -3- 二乙基脲, 收率 99%。 Second step: Nitro reduction: 5 mmoll-p-nitrophenyl-3-diethylurea was dissolved in 20 mL of anhydrous methanol, 90 mg of Raney Ni was added, and 0.469 g (7.5 mmol) of 80% hydrated Add hydrazine dropwise to the reaction solution at room temperature Stir until the reaction is complete, TLC controls the end of the reaction. After filtration, the filtrate was spin-dried to obtain 1.035 g of 1-p-aminophenyl-3-diethylurea in a yield of 99%.
(b) 中间体(Π- 2) 的合成  (b) Synthesis of intermediate (Π-2)
第一步: 以 1-对硝基苯基 -3-(2,4-二氟苯基)脲的合成为例: 氩气保护下, 向 50 mL Schlenck管加入 20 mL无水 THF、 3滴三乙胺和 1.38克( 10 mmol)对硝基苯胺,将 1.20 mL ( 10 mmol) 2, 4-二氟苯基异氰酸酯, 溶解在 10 mL无水 THF, 在室温下缓慢滴加 到反应液中, 回流至反应完全, TLC控制反应终点。 旋干, 在乙酸乙酯重结晶, 收率 52%。  Step 1: Take the synthesis of 1-p-nitrophenyl-3- (2,4-difluorophenyl) urea as an example: Under the protection of argon, add 20 mL of anhydrous THF, 3 drops to a 50 mL Schlenck tube. Triethylamine and 1.38 g (10 mmol) of p-nitroaniline were dissolved in 1.20 mL (10 mmol) of 2,4-difluorophenyl isocyanate in 10 mL of anhydrous THF, and slowly added dropwise to the reaction solution at room temperature. Reflux until the reaction is complete, TLC controls the end of the reaction. Spin-dried and recrystallized from ethyl acetate in 52% yield.
第二步: 硝基还原: 将 5 mmoll-对硝基苯基 -3-(2,4-二氟苯基)脲溶解在 20 mL无水 甲醇中,加入 90mg Raney Ni,将 0.469克(7.5 mmol)的 80%的水合肼滴加到反应液中, 在室温下搅拌至反应完全, TLC控制反应终点。 过滤后, 滤液旋干得 3.1 mmol 1-对氨 基苯基 -3-(2,4-二氟苯基)脲, 收率 62%。  Second step: Nitro reduction: 5 mmoll-p-nitrophenyl-3- (2,4-difluorophenyl) urea was dissolved in 20 mL of anhydrous methanol, 90 mg of Raney Ni was added, and 0.469 g (7.5 80% of hydrazine hydrate was added dropwise to the reaction solution, and stirred at room temperature until the reaction was completed. TLC controlled the end of the reaction. After filtration, the filtrate was spin-dried to obtain 3.1 mmol of 1-p-aminophenyl-3- (2,4-difluorophenyl) urea in a yield of 62%.
(c) 中间体(II -3) 的合成  (c) Synthesis of intermediate (II-3)
第一步:以 1-对硝基苯基 -3-哌啶基脲的合成为例: 2.5克对硝基苯胺溶解在 12.5 mL 的热的冰醋酸中, 2克的氰酸钠加入到反应液中, 快速趁热过滤, 倒入冰水中, 过滤干 燥, 在冰醋酸中重结晶, 得 1.554克对硝基苯基脲, 收率 47.4%。 1.554克对硝基苯基脲 和 15.5 mL哌啶加热回流 8h, 冷却至室温, 旋干, 柱层析(石油醚:乙酸乙酯 = 1:2)得 1.613克纯品, 收率 75.4%。  Step 1: Take the synthesis of 1-p-nitrophenyl-3-piperidinyl urea as an example: 2.5 g of p-nitroaniline is dissolved in 12.5 mL of hot glacial acetic acid, and 2 g of sodium cyanate is added to the reaction. The solution was quickly filtered while hot, poured into ice water, filtered and dried, and recrystallized from glacial acetic acid to obtain 1.554 g of p-nitrophenylurea in a yield of 47.4%. 1.554 g of p-nitrophenylurea and 15.5 mL of piperidine were heated under reflux for 8 hours, cooled to room temperature, and spin-dried. Column chromatography (petroleum ether: ethyl acetate = 1: 2) yielded 1.613 g of pure product with a yield of 75.4%.
第二步: 硝基还原: 将 5 mmoll-对硝基苯基 -3-哌啶基脲溶解在 20 mL无水甲醇中, 加入 90mg Raney Ni, 将 0.469克(7.5 mmol)的 80%的水合肼滴加到反应液中, 在室温 下搅拌至反应完全, TLC控制反应终点。 过滤后, 滤液旋干得 5 mmol 1-对氨基苯基 -3- 哌啶基脲, 收率 99%。  Second step: Nitro reduction: 5 mmoll-p-nitrophenyl-3-piperidinyl urea was dissolved in 20 mL of anhydrous methanol, 90 mg of Raney Ni was added, and 0.469 g (7.5 mmol) of 80% hydrated Hydrazine was added dropwise to the reaction solution and stirred at room temperature until the reaction was complete. TLC controlled the end of the reaction. After filtration, the filtrate was spin-dried to obtain 5 mmol of 1-p-aminophenyl-3-piperidinylurea in a yield of 99%.
2、 2-嘧啶氧基 -N-芳基苄胺化合物的合成 2. Synthesis of 2-pyrimidinyloxy-N-arylbenzylamine compounds
以 1 -1合成为例: Take 1 -1 synthesis as an example:
第一步:与水杨醛缩合:投料釐 4:9 mmoll-对氨基苯基 -3-二乙基脲和 0.717克(5.88 mmol)水杨醛溶解在 15 mL甲醇中, 在室温搅拌至反应完全, TLC控制反应终点。 过 滤得 1.31g黄色固体 (ΙΠ), 收率 86%。  Step 1: Condensation with salicylaldehyde: 4: 9 mmol of l-p-aminophenyl-3-diethylurea and 0.717 g (5.88 mmol) of salicylaldehyde are dissolved in 15 mL of methanol, and stirred at room temperature until the reaction Completely, TLC controls the endpoint of the reaction. Filtration gave 1.31 g of a yellow solid (III) in a yield of 86%.
第二步: Schiff碱还原: 将 1.31g黄色固体 (ΠΙ)加入到 20 mL无水乙醇, 分批加 入 0.242克(6.18 mmol) 97%的硼氢化钠, 在室温下搅拌 30min后, 倒入冰水中, 乙酸 乙酯提取三次, 合并有机相, 饱和食盐水和水各洗一次, 无水硫酸钠干燥, 过滤旋干得 产品 (IV), 收率为 99%。 Step 2: Schiff base reduction: Add 1.31 g of yellow solid (II) to 20 mL of absolute ethanol, add 0.242 g (6.18 mmol) of 97% sodium borohydride in portions, stir at room temperature for 30 min, and pour into ice Water, acetic acid The ethyl acetate was extracted three times, and the organic phases were combined, and the saturated brine and water were washed once, dried over anhydrous sodium sulfate, filtered and spin-dried to obtain the product (IV), with a yield of 99%.
第三步: 与嘧啶砜缩合:  Step 3: Condensation with pyrimidine sulfone:
方法 a: 1.310克(4.2 mmol)亚胺还原的产物(IV)、 0.916克 (4.2 mmol) 嘧啶砜 与 1.159克(8.4 mmol)无水碳酸钾在 50 mL的 1,4-二氧六环中回流 8-9h, TLC控制反 应终点。 冷却至室温, 过滤, 旋干后柱层析 (石油醚:乙酸乙酯 = 2:1 ) 得纯品 1 -1, 收 率 92%。  Method a: 1.310 g (4.2 mmol) of imine-reduced product (IV), 0.916 g (4.2 mmol) of pyrimidine sulfone and 1.159 g (8.4 mmol) of anhydrous potassium carbonate in 50 mL of 1,4-dioxane 8-9h at reflux, TLC controls the end of the reaction. Cool to room temperature, filter, spin dry, and perform column chromatography (petroleum ether: ethyl acetate = 2: 1) to obtain pure product 1-1. The yield is 92%.
方法 b: 1.310克 (4.2 mmol)亚胺还原的产物(IV)、 0.916克 (4.2 mmol) 嘧啶砜 与 1.159克(8.4 mmol)无水碳酸钾在 20 mL的 DMF中室温反应 8-9h, TLC控制反应 终点。 将反应液倒入 800 mL水中, 乙酸乙酯提取三次, 合并有机相, 饱和食盐水和水 各洗一次, 无水硫酸钠干燥, 过滤旋干后柱层析(石油醚:乙酸乙酯 = 2:1 )得纯品 1 -1, 收率 85%。  Method b: 1.310 g (4.2 mmol) of imine-reduced product (IV), 0.916 g (4.2 mmol) of pyrimidine sulfone and 1.159 g (8.4 mmol) of anhydrous potassium carbonate in 20 mL of DMF at room temperature for 8-9 h, TLC Control the endpoint of the reaction. The reaction solution was poured into 800 mL of water, and extracted with ethyl acetate three times. The organic phases were combined, washed with saturated brine and once with water, dried over anhydrous sodium sulfate, filtered and spin-dried, and subjected to column chromatography (petroleum ether: ethyl acetate = 2). : 1) The pure product 1 -1 was obtained with a yield of 85%.
Solid Solid
m.p.: 124.4士 0.5 °C m.p .: 124.4 ± 0.5 ° C
1H NMR (300 MHz, CDC13/TMS): δ 1.23 (6H, t, CH3, J = 7.5Hz), 3.35 (4H, q, CH2, J = 6.6Hz), 3.82 (6H, s, OCH3), 4.31 (2H, s, CH2,), 5.78 (1H, s, CH), 6.09 (1H, s, NH), 6.54-7.47 (8H, m, CH) 1H NMR (300 MHz, CDC1 3 / TMS): δ 1.23 (6H, t, CH 3 , J = 7.5Hz), 3.35 (4H, q, CH 2 , J = 6.6Hz), 3.82 (6H, s, OCH 3 ), 4.31 (2H, s, CH 2 ), 5.78 (1H, s, CH), 6.09 (1H, s, NH), 6.54-7.47 (8H, m, CH)
MS (EI): 245 (m/z, 100), 451 (M+., 5.41)  MS (EI): 245 (m / z, 100), 451 (M +., 5.41)
IR (KBr/cm'1): 3365 (γΝ-Η), 1635 (yc=o), 1602, 1520, 1493 (Yc=c), 1569 (γοΝ), 1218 (y=C-o-c) E. A. for C24H29N504 Calcd: C 63.84, H 6.47, N 15.51 IR (KBr / cm ' 1 ): 3365 (γ Ν-Η ), 1635 (y c = o), 1602, 1520, 1493 ( Yc = c), 1569 (γο Ν ), 1218 (y = C -oc) EA for C 24 H 29 N 5 0 4 Calcd: C 63.84, H 6.47, N 15.51
Found: C 63.72, H 6.36, N 15.82 实施例 2 Found: C 63.72, H 6.36, N 15.82 Example 2
1 -2的合成, 详细实验步骤同实施例 1 : ( 1 ) 与水杨醛缩合: 投料量 5.21 mmoll- 间氨基苯基 -3-二乙基脲, 过滤得 1.620克亚胺物, 收率 99%。 (2) Schiff碱还原: 投料 量 5.21 mmol亚胺物, 得 1.630克'(5.21 mmol) 产品, 收率 99%。 (3 ) 与 P密啶砜缩合: 投料量 1.630克(5.21 mmol)亚胺还原的产物, 柱层析(石油醚:乙酸乙酯 = 2:1 ) 得纯 品, 收率 85%。  The synthesis of 1-2. The detailed experimental steps are the same as in Example 1: (1) Condensation with salicylaldehyde: 5.21 mmoll-m-aminophenyl-3-diethylurea, and 1.620 g of imide are obtained by filtration. Yield 99%. (2) Schiff base reduction: 5.21 mmol of imine was charged to obtain 1.630 g (5.21 mmol) of the product with a yield of 99%. (3) Condensation with P-pyridine sulfone: 1.630 g (5.21 mmol) of the imine-reduced product, and column chromatography (petroleum ether: ethyl acetate = 2: 1) to obtain a pure product with a yield of 85%.
Solid 'm ^ ^Ψ^ ) °%66 ¾1 '^―丄 γ®漭 士敏 Solid 'm : Κ ^ ^ Ψ ^) °% 66 ¾1' ^ ― 丄 γ® 漭 士敏
LYn N 'ί -ζ H 'εΓ650 :P™。J ΐΐ7 ΐ N 'I8'S H '6S D -P^D ^O^D^H^D J0J ΎΉ LYn N 'ί -ζ H' εΓ650: P ™. J ΐΐ7 ΐ N 'I8'S H' 6S D -P ^ D ^ O ^ D ^ H ^ D J0 J ΎΉ
(o-o-o=X) Α9Π (ooo = X) Α9Π
'( ) 1^691 '(3=3人) 11751 '895ΐ 'Α09ΐ '(0=0人) L£9l 1™人) 00££ '( 人) 8ΐ :(Γ-^/¾¾) ¾U '() 1 ^ 691' (= 3 3) 11751 '895ΐ' Α09ΐ '( 0 = 0 person) L £ 9l 1 ™ person) 00 ££' (human) 8ΐ :( Γ- ^ / ¾¾) ¾U
(L6'£ '.+ ΝΙ) '(001 LSI :(13) SW  (L6 '£'. + ΝΙ) '(001 LSI: (13) SW
(HO (HO
'冚 ¾乙) 0ζ-ί-ίΓ9 '(H 's 'Ηΐ) I' X LZ =C C¾D £P ¾S) εΐ7·ΐ7 '(¾ 0 cs ¾9) SL'£ '(ZH69 =/ £¾0 'b 17) £■£ '(ΖΗ6·9 Ί 'Η9) Ι ΐ 9: (S L/ a 'ζ函 00£)環 Ν Ηχ '冚 ¾ 乙) 0ζ-ί-ίΓ9' (H 's' Ηΐ) I 'X LZ = C C ¾D £ P ¾S) εΐ7 · ΐ7' (¾ 0 c s ¾9) SL '£' (ZH69 = / £ ¾0 'b 17) £ ■ £' (ZΗ6 · 9 Ί 'Η9) Ι ΐ 9: (SL / a' ζ function 00 £) ring N Η χ
°%06 傘^ iasmn
Figure imgf000015_0001
6ε'ι喜 诚 ¾ ¾^导来 q¾ ¾f¾ : 驟滅 (t) °%66牽¾1 ( ^rai ¾ 6£ U imm \oOmi m :^¾»U OS °%66傘^ '^一丄 γ¾¾¾士
°% 06 Umbrella ^ ia smn
Figure imgf000015_0001
6ε'ι Xicheng ¾ ¾ ^ leads to q¾ ¾f¾ : quench (t) °% 66 and ¾1 (^ rai ¾ 6 £ U imm \ oOmi m : ^ ¾ »U O S °% 66 umbrella ^ '^ 一 丄γ¾¾¾
9V£l M ^V9 H '8/;£9 D :punoj
Figure imgf000015_0002
9V £ l M ^ V9 H '8 /; £ 9 D: punoj
Figure imgf000015_0002
'(Ν=3人) ζιςι °=D^) η 'βίςι '8βςι '(0=3人) 6£9i '(Η -^) όοεε '(Η'Ν^) 90½ :(T-rao/ie¾) ¾ι '(Ν = 3 persons) ζιςι ° = D ^) η ' βίςι '8βςι' (0 = 3 persons) 6 £ 9i '(Η - ^) όοεε' (Η 'Ν ^) 90½ :( T- rao / ie¾ ) ¾ι
(ιοτ Ί+νύ ζς Χοοι V) ξρ :(ia) s (ιοτ Ί + νύ ζς Χοοι V) ξρ: (ia) s
(H ¾8) LYL-lZ-9 '(H 's ¾ΐ) LL'S 'C¾D 's ¾K) £'t '(¾ 0 's ¾9) 08·ε X YL = Γ '¾0 ¾ 'Hi/) 9Z'£ PVL = '¾ Ί ¾9) ITl §: (S 工 /¾)GD 'zHH 00£) ¾WN Ht (H ¾8) LYL-lZ-9 '(H' s ¾ΐ) LL'S 'C¾D' s ¾K) £ 't' (¾ 0 's ¾9) 08 · ε X YL = Γ' ¾0 ¾ 'Hi /) 9Z' £ PVL = '¾ Ί ¾9) ITl §: (S 工 / ¾) GD' zHH 00 £) ¾WN H t
OSOWOOl :'d'ra OSOWOOl: ' d ' ra
0ZZ,000/1O0ZN3/13d 890/S00Z ΟΛ\ 得 2.639克 (7.694 mmol) 产品, 收率 96%。 (4) 与嘧啶砜縮合: 采用方法 b来合成, 投料量 2.637克 (7.694 mmol ) 亚胺还原的产物, 柱层析 (石油醚:乙酸乙酯 = 2:1 ) 得 纯品, 收率 87%。 0ZZ, 000 / 1O0ZN3 / 13d 890 / S00Z ΟΛ \ There was obtained 2.639 g (7.694 mmol) of the product with a yield of 96%. (4) Condensation with pyrimidine sulfone: Synthesized by method b, with a charge of 2.637 g (7.694 mmol) of the imine-reduced product, and column chromatography (petroleum ether: ethyl acetate = 2: 1) to obtain a pure product, yield 87 %.
Solid Solid
m.p.: 127.5±0.5°C m.p .: 127.5 ± 0.5 ° C
1H NMR (300 MHz, CDC13/TMS): δ 1.24 (6H, t, CH3, J = 8.43Hz), 3.35 (4H, q, CH2, J - 7.14Hz), 3.77 (6H, s, OCH3), 3.87 (3H, s, OCH3), 4.32 (2H, s, CH2,), 5.73 (1H, s, CH), 6.16-7.23 (7H, m, CH) 1H NMR (300 MHz, CDC1 3 / TMS): δ 1.24 (6H, t, CH 3 , J = 8.43Hz), 3.35 (4H, q, CH 2 , J-7.14Hz), 3.77 (6H, s, OCH 3 ), 3.87 (3H, s, OCH 3 ), 4.32 (2H, s, CH 2 ), 5.73 (1H, s, CH), 6.16-7.23 (7H, m, CH)
MS (EI): 275 (m/z, 100), 481 (M+l, 2.01) MS (EI): 275 (m / z, 100), 481 (M + l, 2.01)
IR (KBr/cm'1): 3430 (γΝ-Η), 3289 (γΝ-Η), 1636 (γο=ο), 1612, 1572, 1520 (γα=α), 1589 (yc=N), 1222 (Y=C-o-c) IR (KBr / cm ' 1 ): 3430 (γ Ν-Η ), 3289 (γ Ν-Η ), 1636 (γο = ο), 1612, 1572, 1520 (γα = α), 1589 (y c = N ) , 1222 (Y = C -oc)
E.A. for C25H31N504 Calcd: C 62.36, H 6.49, N 14.54 EA for C 25 H 31 N 5 0 4 Calcd: C 62.36, H 6.49, N 14.54
Found: C 62.55, H 6.50, N 14.65 实施例 5 Found: C 62.55, H 6.50, N 14.65 Example 5
1 -5 的合成, 详细实验步骤同实施例 1 : ( 1 ) 与水杨醛缩合: 投料量 3.434 mmol 氨基物,旋干直接进入下一步。 (2) Schiff碱还原:投料量 3.434 mmol亚胺物,得 1.171 克(3.434 mmol)产品,收率 99%。 (3 )与嘧啶砜缩合:采用方法 a来合成,投料量 1.171 克(3.434 mmol)亚胺还原的产物,柱层析(石油醚:乙酸乙酯 = 2:1 )得纯品,收率 76%。 Solid  For the synthesis of 1-5, the detailed experimental steps are the same as in Example 1: (1) Condensation with salicylaldehyde: 3.434 mmol of amino compound, spin-dry and go directly to the next step. (2) Schiff base reduction: 3.434 mmol of imine is charged to obtain 1.171 g (3.434 mmol) of the product with a yield of 99%. (3) Condensation with pyrimidine sulfone: Synthesized by method a. The input amount of 1.171 g (3.434 mmol) of the imine-reduced product was purified by column chromatography (petroleum ether: ethyl acetate = 2: 1), yield 76. %. Solid
m.p.: 132.5±0.5°C m.p .: 132.5 ± 0.5 ° C
1H NMR (300 MHz, CDC13/TMS): δ 0.96 (6H, t, CH3, J = 7.2Hz), 1.58-1.70 (4H, m, CH2), 3.25 (4H, t, C¾, J = 7.5Hz), 3.82 (6H, s, OCH3), 4.33 (2H, s, CH2), 5.78 (1H, s, CH), 6.02-7.48 (8H, m, CH) 1H NMR (300 MHz, CDC1 3 / TMS): δ 0.96 (6H, t, CH 3 , J = 7.2Hz), 1.58-1.70 (4H, m, CH 2 ), 3.25 (4H, t, C¾, J = 7.5Hz), 3.82 (6H, s, OCH 3 ), 4.33 (2H, s, CH 2 ), 5.78 (1H, s, CH), 6.02-7.48 (8H, m, CH)
MS (EI): 245 (m/z, 100), 479 (M+', 2.70) MS (EI): 245 (m / z, 100), 479 (M + ', 2.70)
IR (KBr/cm-1): 3440(γΝ-Η), 3331 (γΝ-Η), 1641 (yc=0), 1603, 1529, 1483 (yc=c), 1569 (γοΝ), 1222(Y=C-O-C) IR (KBr / cm -1 ): 3440 (γ Ν-Η ), 3331 (γ Ν-Η ), 1641 (y c = 0 ), 1603, 1529, 1483 (y c = c), 1569 (γοΝ), 1222 (Y = C- OC)
E.A. for C26H33N504 Calcd: C 65.12, H 6.94, N 14.60 EA for C 26 H 33 N 5 0 4 Calcd: C 65.12, H 6.94, N 14.60
Found: C 64.89, H 6.87, N 14.39 实施例 6 Found: C 64.89, H 6.87, N 14.39 Example 6
1 -6的合成, 详细实验步骤同实施例 1 : ( 1 ) 与 6-氯水杨醛缩合: 投料量 5 mmol 氨基物, 旋干直接进入下一步, 收率 99%。 (2 ) Schiff碱还原: 投料量 5 mmol亚胺物, 得 1.887克(5 mmol)产品, 收率 99%。 (4 )与嘧啶砜缩合: 采用方法 b来合成, 投料 量 1.887克 (5 mmol )亚胺还原的产物, 柱层析 (石油醚:乙酸乙酯 = 5: 1 ) 得纯品, 收 率 80%。  For the synthesis of 1-6, the detailed experimental steps are the same as those in Example 1: (1) Condensation with 6-chlorosalicylic aldehyde: Amount of 5 mmol of amino compound, spin-drying and directly into the next step, the yield is 99%. (2) Schiff base reduction: 5 mmol of imine is charged to obtain 1.887 g (5 mmol) of the product with a yield of 99%. (4) Condensation with pyrimidine sulfone: Synthesized by method b. The input amount of 1.887 g (5 mmol) of the imine-reduced product was obtained by column chromatography (petroleum ether: ethyl acetate = 5: 1). The pure product was obtained in a yield of 80. %.
Solid Solid
m.p.: 90.1±0.5 °C m.p .: 90.1 ± 0.5 ° C
1H NMR (300 MHz, CDC13/TMS): δ 0.94 (6H, t, CH3, J = 7.5Hz), 1.57-1.70 (4H, m, CH2), 3.24 (4H, t, CH2, J = 7.5Hz), 3.79 (6H, s, OCH3), 4.45 (2H, s, CH2), 5.76 (1H, s, CH), 6.23 (1H, s, NH), 6.31-7.31 (7H, m, CH) 1H NMR (300 MHz, CDC13 / TMS): δ 0.94 (6H, t, CH 3 , J = 7.5Hz), 1.57-1.70 (4H, m, CH 2 ), 3.24 (4H, t, CH 2 , J = 7.5Hz), 3.79 (6H, s, OCH 3 ), 4.45 (2H, s, CH 2 ), 5.76 (1H, s, CH), 6.23 (1H, s, NH), 6.31-7.31 (7H, m, CH)
MS (EI): 157 (m/z, 100), 513 (M "., 15.36) MS (EI): 157 (m / z, 100), 513 (M "., 15.36)
IR (KBr/cm"1): 3438 (γΝ-Η), 3373 (γΝ-Η), 1641 (γο0), 1596, 1545, 1484 (yc=c), 1230 (Y=C-O-C) E.A. for C26H32C1N504 Calcd: C 60.75, H 6.27, N 13.62 IR (KBr / cm " 1 ): 3438 (γ Ν-Η ), 3373 (γ Ν-Η ), 1641 (γο 0 ), 1596, 1545, 1484 (y c = c), 1230 (Y = C -OC ) EA for C 26 H 32 C1N 5 0 4 Calcd: C 60.75, H 6.27, N 13.62
Found: C 60.58, H 6.22, N 13.58 实施例 7 Found: C 60.58, H 6.22, N 13.58 Example 7
I -7的合成,详细实验步骤同实施例 1: ( 1 )与 6-甲氧基水杨醛缩合:投料量 5.4 mmol 氨基物,旋干直接进入下一步,收率 99%。 (2 ) Schiff碱还原:投料量 5.4 mmol亚胺物, 得 1.984克(5.35 mmol)产品, 收率 99%。 (4 )与嘧啶砜缩合: 采用方法 b来合成, 投 料量 2.637克 (7.694 mmol) 亚胺还原的产物, 柱层析 (石油醚:乙酸乙酯 = 2: 1 ) 得纯 品, 收率 85%。  For the synthesis of I-7, the detailed experimental steps are the same as in Example 1: (1) Condensation with 6-methoxysalicylic aldehyde: Amount of 5.4 mmol of amino compound, spin-drying and directly into the next step, the yield is 99%. (2) Schiff base reduction: 5.4 mmol of imine is charged to obtain 1.984 g (5.35 mmol) of the product with a yield of 99%. (4) Condensation with pyrimidine sulfone: Synthesized by method b, with a charge of 2.637 g (7.694 mmol) of the imine-reduced product, and column chromatography (petroleum ether: ethyl acetate = 2: 1) to obtain a pure product with a yield of 85. %.
Solid Solid
m.p.: 126.0±0.5 °C m.p .: 126.0 ± 0.5 ° C
1H NMR (300 MHz, CDC13/TMS): δ 0.87 (6H, t, CH3, J = 9Hz), 1.58-1.70 (4H, m, CH2), 3.24 (4H, t, CH2, J= 6.5Hz), 3.78 (6H, s, OCH3), 3.88 (3H, s, OCH3), 4.33( 2H, s, CH2), 5.74 (1H, s, CH), 6.17 (1H, s, NH), 6.29-7.28 (7H, m, CH) 1H NMR (300 MHz, CDC1 3 / TMS): δ 0.87 (6H, t, CH 3 , J = 9Hz), 1.58-1.70 (4H, m, CH 2 ), 3.24 (4H, t, CH 2 , J = 6.5Hz), 3.78 (6H, s, OCH 3 ), 3.88 (3H, s, OCH 3 ), 4.33 (2H, s, CH 2 ), 5.74 (1H, s, CH), 6.17 (1H, s, NH ), 6.29-7.28 (7H, m, CH)
MS (EI): 275 (m/z, 100), 509 (Μ+·, 2.70) MS (EI): 275 (m / z, 100), 509 (Μ + ·, 2.70)
IR (cm-1): 3433 (γΝ-Η), 3333 (γΝ-Η), 1643 (γο0), 1600, 1552, 1480 (yc=c), 1576 (γα=Ν), 1196 (Y=c-o-c) E.A. for C27H35N505 Calcd: C 63.64, H 6.92, N 13.74 IR (cm- 1 ): 3433 (γ Ν-Η ), 3333 (γ Ν-Η ), 1643 (γο 0 ), 1600, 1552, 1480 (y c = c), 1576 (γ α = Ν ), 1196 (Y = coc) EA for C 27 H 35 N 5 0 5 Calcd: C 63.64, H 6.92, N 13.74
Found: C 63.44, H 6.90, N 13.46 实施例 8 Found: C 63.44, H 6.90, N 13.46 Example 8
I -8的合成, 详细实验步骤同实施例 1 : ( 1 ) 与水杨醛縮合: 投料量 3.35 mmol氨 基物, 过滤得 1.229克亚胺物, 收率 99%。 (2 ) Schiff碱还原: 投料量 3.3 mmol亚胺物, 得 1.218克 (3.3 mmol)产品, 收率 99%。 (3 ) 与嘧啶砜縮合: 采用方法 a来合成, 投 料量 1.218克 (3.3 mmol)亚胺还原的产物, 柱层析(石油醚:乙酸乙酯 = 2: 1 )得纯品, 收率 90%。  For the synthesis of I-8, the detailed experimental steps are the same as in Example 1: (1) Condensation with salicylaldehyde: 3.35 mmol of amino compound was fed, and 1.229 g of imine was obtained by filtration, with a yield of 99%. (2) Schiff base reduction: 3.3 mmol of imide is charged to obtain 1.218 g (3.3 mmol) of the product with a yield of 99%. (3) Condensation with pyrimidine sulfone: Synthesized by method a. The amount of the imine-reduced product was 1.218 g (3.3 mmol). Column chromatography (petroleum ether: ethyl acetate = 2: 1) yielded pure product. Yield: 90. %.
Solid Solid
m.p.: 118.0±0.5 °C m.p .: 118.0 ± 0.5 ° C
1H NMR (300 MHz, CDC13/TMS): δ 0.95 (6H, t, CH3, J = 7.2Hz), 1.28-1.41 (4H, m, CH2), 1.53-1.63 (4H, m, CH2), 3.25 (4H, t, CH2, J= 7.2Hz), 3.82 (6H, s, OCH3), 4.30 (2H, s, CH2), 5.77 (1H, s, CH), 6.01 (1H, s, NH), 6.54 (2H,d, CH, J= 8.7Hz), 7.08-7.45 (6H, m, CH) MS (EI): 275 m/z, 100), 507 CM ', 5.14) 1H NMR (300 MHz, CDC13 / TMS): δ 0.95 (6H, t, CH 3 , J = 7.2Hz), 1.28-1.41 (4H, m, CH 2 ), 1.53-1.63 (4H, m, CH 2 ) , 3.25 (4H, t, CH 2 , J = 7.2Hz), 3.82 (6H, s, OCH 3 ), 4.30 (2H, s, CH 2 ), 5.77 (1H, s, CH), 6.01 (1H, s , NH), 6.54 (2H, d, CH, J = 8.7Hz), 7.08-7.45 (6H, m, CH) MS (EI): 275 m / z, 100), 507 CM ', 5.14)
IR (KBr/cm"1): 3354(γΝH), 1631 (yc=o), 1600, 1521, 1490 (yc=c), 1572 (γα=Ν), 1220 (y=C-o-c) E.A. for C28H37N504 Calcd: C 66.25, H 7.35, N 13.80 IR (KBr / cm " 1 ): 3354 (γ ΝH ), 1631 (y c = o), 1600, 1521, 1490 (y c = c ), 1572 (γ α = Ν ), 1220 (y = C -oc) EA for C 28 H 37 N 5 0 4 Calcd: C 66.25, H 7.35, N 13.80
Found: C 66.10, H 7.29, N 13.72 实施例 9 Found: C 66.10, H 7.29, N 13.72 Example 9
1 -9的合成, 详细实验步骤同实施例 1 : ( 1 ) 与水杨醛缩合: 投料量 3 mmol氨基 物,旋干直接进入下一步。 (2 ) Schiff碱还原:投料量 3 mmol亚胺物,得 1.099克(2.98 mmol)产品, 收率 99%。 (3 ) 与嘧啶砜缩合: 采用方法 a或 b来合成, 投料量 1.099 克(2.98 mmol )亚胺还原的^物,柱层析(石油醚:乙酸乙酯 = 2: 1 )得纯品,收率 75.2%。 Solid  For the synthesis of 1-9, the detailed experimental steps are the same as in Example 1: (1) Condensation with salicylaldehyde: The amount of 3 mmol of amino compound is charged, and it is spin-dried directly to the next step. (2) Schiff base reduction: 3 mmol of imine is charged to obtain 1.099 g (2.98 mmol) of the product with a yield of 99%. (3) Condensation with pyrimidine sulfone: Synthesized by method a or b. The feed amount is 1.099 g (2.98 mmol) of the imine-reduced product, and column chromatography (petroleum ether: ethyl acetate = 2: 1) is used to obtain the pure product. The yield was 75.2%. Solid
m.p.: 96.3±0.5 °C m.p .: 96.3 ± 0.5 ° C
1H NMR (300 MHz, CDC13/TMS): δ 0.95 (6H, t, CH3), 1.30-1.39 (4H, m, CH2), 1.54-1.61 (4H, m, CH2), 2.63 (1H, s, NH), 3.27 (4H, t, CH2, J= 7.5Hz), 3.77 (1H, m, NH), 3.81 (6H, s, OCH3), 4.35 (2H, s, CH2), 5.77 (1H, s, CH), 6.23-7.49 (8H, m, CH) 1H NMR (300 MHz, CDC1 3 / TMS): δ 0.95 (6H, t, CH 3 ), 1.30-1.39 (4H, m, CH 2 ), 1.54-1.61 (4H, m, CH 2 ), 2.63 (1H , s, NH), 3.27 (4H, t, CH 2 , J = 7.5Hz), 3.77 (1H, m, NH), 3.81 (6H, s, OCH 3 ), 4.35 (2H, s, CH 2 ), 5.77 (1H, s, CH), 6.23-7.49 (8H, m, CH)
MS (EI): 245 (m/z, 100), 507 (Μ+·, 21.78) IR (KBr/cm"1): 3419 (γΝ-Η), 3309 (γΝ-Η), 1637 (yc=o), 1600, 1535, 1455 (Yc=c), 1569 (γ0=Ν) E.A. for C28H37N504 Calcd: C 66.25, H 7.35, N 13.80 MS (EI): 245 (m / z, 100), 507 (Μ + ·, 21.78) IR (KBr / cm " 1 ): 3419 (γ Ν-Η ), 3309 (γ Ν-Η ), 1637 (y c = o), 1600, 1535, 1455 ( Yc = c ), 1569 (γ 0 = Ν ) EA for C 28 H 37 N 5 0 4 Calcd: C 66.25, H 7.35, N 13.80
Found: C 66.10, H 7.29, N 13.72 实施例 10 Found: C 66.10, H 7.29, N 13.72 Example 10
I -10的合成, 详细实验步骤同实施例 1 : ( 1 ) 与 6-氯水杨醛缩合: 投料量 3 mmol 氨基物, 过滤得 1.003克亚胺物, 收率 83%。 (2 ) Schiff碱还原: 投料量 2.5 mmol亚胺 物, 得 0.824克 (2.042 mmol)产品, 收率 82%。 (4) 与嘧啶砜缩合: 采用方法 b来合 成, 投料量 0.824克 (2 mmol)亚胺还原的产物, 柱层析 (石油醚:乙酸乙酯 = 1 : 1 ) 得 纯品, 收率 95%。  For the synthesis of I-10, the detailed experimental steps are the same as those in Example 1: (1) Condensation with 6-chlorosalicylic aldehyde: the amount of 3 mmol of amino compound was filtered to obtain 1.003 g of imine, with a yield of 83%. (2) Schiff base reduction: 2.5 mmol of imine is charged to obtain 0.824 g (2.042 mmol) of the product with a yield of 82%. (4) Condensation with pyrimidine sulfone: Synthesized by method b, 0.824 g (2 mmol) of imine-reduced product, and column chromatography (petroleum ether: ethyl acetate = 1: 1) to obtain pure product. Yield: 95. %.
Oil Oil
1H NMR (300 MHz, CDC13/TMS): δ 0.96 (6Η, t, CH3, J = 7.2Hz), 1.30-1.42 (4H, m, CH2), 1.54-1.64 (4H, m, CH2), 3.27 (4H, t, CH2, J= 7.5Hz), 3.79 (6H, s, OCH3), 4.43 (2H, s, CH2), 5.76 (1H, s, CH), 6.20 (1H, s, NH), 6.27-7.31 (7H, m, CH) 1H NMR (300 MHz, CDC1 3 / TMS): δ 0.96 (6Η, t, CH 3 , J = 7.2Hz), 1.30-1.42 (4H, m, CH 2 ), 1.54-1.64 (4H, m, CH 2 ), 3.27 (4H, t, CH 2 , J = 7.5Hz), 3.79 (6H, s, OCH 3 ), 4.43 (2H, s, CH 2 ), 5.76 (1H, s, CH), 6.20 (1H, s, NH), 6.27-7.31 (7H, m, CH)
MS (EI): 157 (m/z, 100), 541 (M+., 4.75) MS (EI): 157 (m / z, 100), 541 (M + ., 4.75)
IR (neat/cm-1): 3420 (γΝ-Η), 3292 (γΝ-Η), 1638 (yc=0), 1605, 1536, 1471 (yc=c), 1565 (yc=N), 1226, 1195, 1166 (y=c-o-c) IR (neat / cm -1 ): 3420 (γ Ν-Η ), 3292 (γ Ν-Η ), 1638 (y c = 0 ), 1605, 1536, 1471 (y c = c), 1565 (y c = N ), 1226, 1195, 1166 (y = c- oc)
E.A. for C28H36C1N504 Calcd: C 62.04, H 6.69, N 12.92 EA for C 28 H 36 C1N 5 0 4 Calcd: C 62.04, H 6.69, N 12.92
Found: C 61.91 , H 6.67, N 12.72 实施例 11 Found: C 61.91, H 6.67, N 12.72 Example 11
I -11的合成, 详细实验步骤同实施例 1 : ( 1 ) 与 6-甲氧基水杨醛缩合: 投料量 2.5 mmol氨基物, 旋干直接进入下一步, 收率 99%。 (2 ) Schiff碱还原: 投料量 2.5 mmol 亚胺物, 得 0.913克 (2.29 mmol )产品, 收率 92%。 (4 ) 与嘧啶砜缩合: 釆用方法 b 来合成,投料量 0.913克(2.29 mmol)亚胺还原的产物,柱层析(石油醚:乙酸乙酯 = 2: 1 ) 得纯品, 收率 85%。  For the synthesis of I-11, the detailed experimental steps are the same as in Example 1: (1) Condensation with 6-methoxysalicylic aldehyde: The amount of the amino compound is 2.5 mmol, which is directly dried by spin-drying, and the yield is 99%. (2) Schiff base reduction: 2.5 mmol of imide is charged to obtain 0.913 g (2.29 mmol) of the product with a yield of 92%. (4) Condensation with pyrimidine sulfone: 釆 Synthesized by method b, 0.913 g (2.29 mmol) of imine-reduced product, and column chromatography (petroleum ether: ethyl acetate = 2: 1) to obtain pure product. Yield. 85%.
Solid Solid
m.p.: 78.3±0.5 °C m.p .: 78.3 ± 0.5 ° C
1H NMR (300 MHz, CDC13/TMS): δ 0.97 (6H, t, CH3, J = 7.2Hz), 1.30-1.43 (4H, m, CH2), 1.54-1.64 (4H, m, CH2), 3.27 (4H, t, CH2, J= 7.2Hz), 3.79 (6H, s, OC¾), 3.88 (3H, s, OCH3), 4.35 (2H, s, CH2), 5.75 (1H, s, CH), 6.20 (1H, s, NH), 6.32-7.28 (7H, m, CH) MS (EI): 275 (m/z, 100), 538 (Μ+·, 4.75) 1H NMR (300 MHz, CDC1 3 / TMS): δ 0.97 (6H, t, CH 3 , J = 7.2Hz), 1.30-1.43 (4H, m, CH 2 ), 1.54-1.64 (4H, m, CH 2 ), 3.27 (4H, t, CH 2 , J = 7.2Hz), 3.79 (6H, s, OC¾), 3.88 (3H, s, OCH 3 ), 4.35 (2H, s, CH 2 ), 5.75 (1H, s, CH), 6.20 (1H, s, NH), 6.32-7.28 (7H, m, CH) MS (EI): 275 (m / z, 100 ), 538 (Μ + ·, 4.75)
IR (KBr/cm"1): 3405 (γΝ-Η), 3340 (γΝ-Η), 1645 (γα=0), 1600, 1544, 1469 (yc=c), 1570 (yc=N), 1220, 1196, 1166 (Y=C.0-C) IR (KBr / cm " 1 ): 3405 (γ Ν-Η ), 3340 (γ Ν - Η ), 1645 (γ α = 0 ), 1600, 1544, 1469 (y c = c), 1570 (y c = N ), 1220, 1196, 1166 (Y = C. 0- C)
E.A. for C29H39N505 Calcd: C 64.78, H 7.31, N 13.03 EA for C 29 H 39 N 5 0 5 Calcd: C 64.78, H 7.31, N 13.03
Found: C 64.72, H 7.36, N 13.00 实施例 12 Found: C 64.72, H 7.36, N 13.00 Example 12
1 -12的合成, 详细实验步骤同实施例 1 : ( 1 ) 与水杨醛缩合: 投料量 6.48 mmol 氨基物, 过滤得 1.589克亚胺物, 收率 76%%。 (2 ) Schiff碱还原: 投料量 4.92 mmol 亚胺物, 得 1.465克 (4.51 mmol ) 产品, 收率 92%。 (3 ) 与嘧啶砜缩合: 采用方法 a 来合成,投料量 1.465克(4.51 mmol )亚胺还原的产物,柱层析(石油醚:乙酸乙酯 = 2: 1 ) 得纯品, 收率 89%。  For the synthesis of 1-12, the detailed experimental steps are the same as in Example 1: (1) Condensation with salicylaldehyde: the amount of 6.48 mmol of amino compound was filtered, and 1.589 g of imine was obtained by filtration, with a yield of 76 %%. (2) Schiff base reduction: 1.92 mmol (4.51 mmol) of the product is obtained with a charge of 4.92 mmol of imine, and the yield is 92%. (3) Condensation with pyrimidine sulfone: Synthesized by method a. The input amount of 1.465 g (4.51 mmol) of the imine-reduced product was purified by column chromatography (petroleum ether: ethyl acetate = 2: 1). The yield was 89. %.
Solid Solid
m.p.: 76.3±0.5 °C m.p .: 76.3 ± 0.5 ° C
1H NMR (300 MHz, CDC13/TMS): δ 1.60 (6H, m, CH2), 3.40 (4H, q, CH2), 3.80 (6H, s, OCH3), 4.29 (2H, s, C¾,), 5.77 (1H, s, CH), 6.12 (1H, s, NH), 6.50 (2H, d, CH, J = 8.4Hz), 7.04-7.45 (6H, m, CH) 1H NMR (300 MHz, CDC1 3 / TMS): δ 1.60 (6H, m, CH 2 ), 3.40 (4H, q, CH 2 ), 3.80 (6H, s, OCH 3 ), 4.29 (2H, s, C¾ ,), 5.77 (1H, s, CH), 6.12 (1H, s, NH), 6.50 (2H, d, CH, J = 8.4Hz), 7.04-7.45 (6H, m, CH)
13C NMR (75.5 MHz, CDC13): δ 24.42, 25.67, 43.62, 45.20, 54.22, 84.58, 113.26, 122.54, 122.78, 125.70, 128.06, 128.91 , 129.50, 131.70, 144.46, 150.89, 155.80, 164.27, 172.98 MS (EI): 245 (m/z, 100), 463 (Μ+·, 5.53) 13 C NMR (75.5 MHz, CDC1 3 ): δ 24.42, 25.67, 43.62, 45.20, 54.22, 84.58, 113.26, 122.54, 122.78, 125.70, 128.06, 128.91, 129.50, 131.70, 144.46, 150.89, 155.80, 164.27. MS, 172.98 (EI): 245 (m / z, 100), 463 (Μ + ·, 5.53)
IR (KBr/cm"1): 3333 (γΝ-Η), 1635 (yc=o), 1601 , 1519, 1417 (γ0=ο), 1571 (γοΝ), 1218 (y=C-o-c) HRMS for C25H29N504 Calcd: 463.22194; Found: 463.21762 实施例 13 IR (KBr / cm " 1 ): 3333 (γ Ν-Η ), 1635 (y c = o), 1601, 1519, 1417 (γ 0 = ο), 1571 (γο Ν ), 1218 (y = C -oc ) HRMS for C 25 H 29 N 5 0 4 Calcd: 463.22194; Found: 463.21762 Example 13
1 -13 的合成, 详细实验步骤同实施例 1 : ( 1 ) 与水杨醛縮合: 投料量 7.18 mmol 氨基物, 过滤得 1.746克亚胺物, 收率 63.2%。 (2 ) Schiff碱还原: 投料量 4.66 mmol 亚胺物, 得 1.712克 (4.541 mmol ) 产品, 收率 99%。 (3 ) 与嘧啶砜缩合: 釆用方法 a 来合成, 投料量 1.712克 (4.541 mmol )亚胺还原的产物, 柱层析(石油醚:乙酸乙酯 = 2: 1 ) 得纯品, 收率 93%。 For the synthesis of 1-13, the detailed experimental steps are the same as those in Example 1: (1) Condensation with salicylaldehyde: A feed amount of 7.18 mmol of an amino compound was filtered to obtain 1.746 g of an imine with a yield of 63.2%. (2) Schiff base reduction: 4.66 mmol of imine is charged to obtain 1.712 g (4.541 mmol) of the product with a yield of 99%. (3) Condensation with pyrimidine sulfone: (1) Synthesis by method a. The amount of the imine-reduced product was 1.712 g (4.541 mmol). Column chromatography (petroleum ether: ethyl acetate = 2: 1) The pure product was obtained with a yield of 93%.
Solid Solid
m.p.: 分解 m.p .: decomposition
1H NMR (300 MHz, CD3COCD3): δ 1.34 (3H, t, CH3, J = 6.9Hz), 3.81 (6H, s, OCH3), 4.00 (2H, q, CH2, J = 7.5Hz), 4.29 (2H, d, CH2, J = 5.1Hz), 5.85 (1H, s, CH), 6.53-7.73 (13H, m, CH) 1H NMR (300 MHz, CD3COCD3): δ 1.34 (3H, t, CH 3 , J = 6.9Hz), 3.81 (6H, s, OCH 3 ), 4.00 (2H, q, CH 2 , J = 7.5Hz), 4.29 (2H, d, CH 2 , J = 5.1Hz), 5.85 (1H, s, CH), 6.53-7.73 (13H, m, CH)
MS (EI): 245 (m/z, 100), 515 (Μ+·, 8.72)  MS (EI): 245 (m / z, 100), 515 (Μ + ·, 8.72)
IR (KBr/cn 1): 3271 (γΝ-Η), 1643 (γο。), 1615, 1514, 1474 (jc=c), 1566 (yc=N), 1224, 1197, 1172 (Y=C-O-C) IR (KBr / cn 1 ): 3271 (γ Ν-Η ), 1643 (γο.), 1615, 1514, 1474 (j c = c), 1566 (y c = N ), 1224, 1197, 1172 (Y = COC)
HRMS for C28H29N505 Calcd: 515.21685; Found: 515.21429 实施例 14 HRMS for C 28 H 29 N 5 0 5 Calcd: 515.21685; Found: 515.21429 Example 14
I -14的合成, 详细实验步骤同实施例 1 : ( 1 ) 与水杨醛缩合: 投料量 4.855 mmol 氨基物, 过滤得 1.654克亚胺物, 收率 84%。 (2) Schiff碱还原: 投料量 4.61 mmol亚 胺物, 得 1.593克 (4.413 mmol ) 产品, 收率 96%。 (3 )与嘧啶砜缩合: 采用方法 a来 合成,投料量 1.593克(4.413 mmol)亚胺还原的产物,柱层析(石油醚:乙酸乙酯 = 2: 1 ) 得纯品, 收率 90%。  The synthesis of I -14. The detailed experimental steps are the same as those in Example 1: (1) Condensation with salicylaldehyde: 4.855 mmol of amino compound, which is filtered to obtain 1.654 g of imine, with a yield of 84%. (2) Schiff base reduction: 4.61 mmol of imide is charged to obtain 1.591 g (4.413 mmol) of the product with a yield of 96%. (3) Condensation with pyrimidine sulfone: Synthesized by method a. The amount of the imine-reduced product was 1.593 g (4.413 mmol). Column chromatography (petroleum ether: ethyl acetate = 2: 1) yielded pure product. Yield: 90. %.
Solid Solid
m.p.: 190.8±0.5 °C m.p .: 190.8 ± 0.5 ° C
1H NMR (300 MHz, CDCI3/TMS): δ 2.09 (3H, s, CH3), 2.32 (3H, s, CH3), 3.81 (6H, s, OCH3), 4.23 (1H, s, NH), 4.33 (2H, s, CH2), 5.78 (1H, s, CH), 6.11-7.47 (13H, m) 1H NMR (300 MHz, CDCI3 / TMS): δ 2.09 (3H, s, CH 3 ), 2.32 (3H, s, CH 3 ), 3.81 (6H, s, OCH3), 4.23 (1H, s, NH), 4.33 (2H, s, CH 2 ), 5.78 (1H, s, CH), 6.11-7.47 (13H, m)
MS (EI): 275 ( /z, 100), 499 (M+., 14.74) MS (EI): 275 (/ z, 100), 499 (M +., 14.74)
IR (KBr/cm"1): 3400 (γΝ-Η), 3288 (γΝ-Η), 1646 (γ0=ο), 1602, 1520, 1491 (γα=ο), 1559 (γοΝ), 1218, 1195 (Y=C-O-C) IR (KBr / cm " 1 ): 3400 (γ Ν-Η ), 3288 (γ Ν-Η ), 1646 (γ 0 = ο), 1602, 1520, 1491 (γ α = ο), 1559 (γο Ν ) , 1218, 1195 (Y = C -OC)
Ε.Α. for C28H29N504 Calcd: C 67.32, H 5.85, N 14.02 Ε.Α. for C 28 H 29 N 5 0 4 Calcd: C 67.32, H 5.85, N 14.02
Found: C 67.19, H 6.05, N 14.00 实施例 15 Found: C 67.19, H 6.05, N 14.00 Example 15
I -15的合成, 详细实验步骤同实施例 1 : ( 1 ) 与水杨醛缩合: 投料量 6.9 mmol氨 基物,旋干后直接进入下一步,收率 99%。 (2 ) Schiff碱还原:投料量 6.9 mmol亚胺物, 得 2.12克(6.1 mmol)产品, 收率 88%。 (3 )与嘧啶砜缩合: 釆用方法 b来合成, 投料 量 2.12克 (6.1 mmol)亚胺还原的产物, 柱层析(石油醚:乙酸乙酯 = 2: 1 )得纯品, 收 率 75%。 Synthesis of I-15, detailed experimental steps are the same as in Example 1: (1) Condensation with salicylaldehyde: 6.9 mmol ammonia The substrate was directly dried after spinning, and the yield was 99%. (2) Schiff base reduction: A feed amount of 6.9 mmol of imine yields 2.12 g (6.1 mmol) of the product with a yield of 88%. (3) Condensation with pyrimidine sulfone: 合成 Synthesized by method b. The amount of the imine-reduced product was 2.12 g (6.1 mmol). Column chromatography (petroleum ether: ethyl acetate = 2: 1) yielded pure product. 75%.
Solid Solid
m.p.: 分解 m.p .: decomposition
1H NMR (300 MHz, CDC13/TMS): 3.80 (6H, s, OCH3), 4.29 (2H, s, CH2), 5.77 (1H, s, CH), 6.28-7.42 (14H, m) 1H NMR (300 MHz, CDC1 3 / TMS): 3.80 (6H, s, OCH 3 ), 4.29 (2H, s, CH 2 ), 5.77 (1H, s, CH), 6.28-7.42 (14H, m)
19F NMR (282 MHz, CD): δ -119.37 (IF, s) 19 F NMR (282 MHz, CD): δ -119.37 (IF, s)
MS (EI): 245 (m/z, 100), 489 (M+., 3.56) MS (EI): 245 (m / z, 100), 489 (M +., 3.56)
IR (KBr/cm"1): 3275 (γΝ-Η), 1668, 1647 (yc=o), 1600, 1509, 1472 (yc=c), 1571 (γ0=Ν), 1217, 1166 (y=c-o-c) IR (KBr / cm " 1 ): 3275 (γ Ν-Η ), 1668, 1647 (y c = o), 1600, 1509, 1472 (y c = c), 1571 (γ 0 = Ν ), 1217, 1166 (y = c- oc)
E.A. for C26H24FN504 Calcd: C 63.80, H 4.94, N 14.31 EA for C 26 H 24 FN 5 0 4 Calcd: C 63.80, H 4.94, N 14.31
Found: C 63.70, H 4.74, N 14.21 实施例 16 Found: C 63.70, H 4.74, N 14.21 Example 16
1 -16 的合成, 详细实验步骤同实施例 1 : ( 1 ) 与水杨醛缩合: 投料量 3.34 mmol 氨基物, 过滤得 1.166克亚胺物, 收率 99%。 (2 ) Schiff碱还原: 投料量 3.34 mmol亚 胺物, 得 1.116克(3.18 mmol )产品, 收率 95%。 (3 )与嘧啶砜缩合: 釆用方法 b来合 成, 投料量 1.116克 (3.18 mmol) 亚胺还原的产物, 柱层析 (石油醚:乙酸乙酯 = 2: 1 ) 得纯品, 收率 75%。  For the synthesis of 1-16, the detailed experimental steps are the same as in Example 1: (1) Condensation with salicylaldehyde: 3.34 mmol of amino compound was filtered, and 1.166 g of imide was filtered, and the yield was 99%. (2) Schiff base reduction: 3.34 mmol of imide is charged to obtain 1.116 g (3.18 mmol) of the product with a yield of 95%. (3) Condensation with pyrimidine sulfone: 合成 Synthesized by method b, 1.116 g (3.18 mmol) of the imine-reduced product was charged, and column chromatography (petroleum ether: ethyl acetate = 2: 1) was obtained as a pure product in a yield. 75%.
Solid Solid
m.p.: 分解 m.p .: decomposition
1H NMR (300 MHz, CDC13/TMS): 3.81 (6H, s, OCH3), 4.32 (2H, s, CH2), 5.78 (1H, s, CH),1H NMR (300 MHz, CDC1 3 / TMS): 3.81 (6H, s, OCH 3 ), 4.32 (2H, s, CH 2 ), 5.78 (1H, s, CH),
6.50-7.45 (12H, m, CH) 6.50-7.45 (12H, m, CH)
19F NMR (282 MHz, CD): δ -119.71 (IF, s) 19 F NMR (282 MHz, CD): δ -119.71 (IF, s)
MS (EI): 245 (m/z, 100), 489 (Μ+·, 4.08) MS (EI): 245 (m / z, 100), 489 (Μ + ·, 4.08)
IR (KBr/cm"1): 3400 (γΝ.Η), 3301 (γΝ-Η), 1643 (γα=ο), 1602, 1521, 1510 (jc=c), 1568 (γα=Ν), 1197 (T=c-o-c) IR (KBr / cm " 1 ): 3400 (γ Ν . Η ), 3301 (γ Ν-Η ), 1643 (γ α = ο), 1602, 1521, 1510 (j c = c), 1568 (γ α = Ν ), 1197 ( T = coc)
E.A. for C26H24FN504 Calcd: C 63.80, H 4.94, N 14.31 Found: C 63.76, H 4.67, N 14.32 实施例 17 EA for C 26 H 24 FN 5 0 4 Calcd: C 63.80, H 4.94, N 14.31 Found: C 63.76, H 4.67, N 14.32 Example 17
1 -17的合成, 详细实验步骤同实施例 1 : ( 1 ) 与水杨醛缩合: 投料量 3.18 mmol 氨基物, 过滤得 1.167克亚胺物, 收率 99%。 (2 ) Schiff碱还原: 投料量 3.18 mmol亚 胺物, 得 1.125克(3.05 mmol )产品, 收率 96%。 (3 )与嘧啶砜缩合: 采用方法. a来合 成, 投料量 1.125克 (3.05 mmol)亚胺还原的产物, 柱层析 (石油醚:乙酸乙酯 = 2: 1 ) 得纯品, 收率 40%。  For the synthesis of 1-17, the detailed experimental steps are the same as those in Example 1: (1) Condensation with salicylaldehyde: 3.18 mmol of amino compound, and 1.167 g of imine were obtained by filtration, with a yield of 99%. (2) Schiff base reduction: 3.18 mmol of imide is charged to obtain 1.125 g (3.05 mmol) of the product with a yield of 96%. (3) Condensation with pyrimidine sulfone: It was synthesized by method a. The amount of the imine-reduced product was 1.125 g (3.05 mmol). Column chromatography (petroleum ether: ethyl acetate = 2: 1) was used to obtain the pure product. Yield. 40%.
Solid Solid
m.p.: 分解 m.p .: decomposition
1H NMR (300 MHz, CD3COCD3): 3.80 (6H, s, OCH3), 4.29 (2H, d, CH2, J = 5.4Hz), 4.351H NMR (300 MHz, CD 3 COCD 3 ): 3.80 (6H, s, OCH 3 ), 4.29 (2H, d, CH 2 , J = 5.4Hz), 4.35
(1H, s, NH), 5.30 (1H, s, NH), 5.85 (1H, s, CH), 6.54-8.28 (12H, m, CH) (1H, s, NH), 5.30 (1H, s, NH), 5.85 (1H, s, CH), 6.54-8.28 (12H, m, CH)
19F NMR (282 MHz, CD3COCD3): δ -120.89 (IF, t, J = 14.66Hz), -128.62 (IF, t, J = 19 F NMR (282 MHz, CD 3 COCD 3 ): δ -120.89 (IF, t, J = 14.66Hz), -128.62 (IF, t, J =
11.56Hz) 11.56Hz)
MS (EI): 108 (m/z, 100), 507 (Μ"*"·, 9.60)  MS (EI): 108 (m / z, 100), 507 (Μ "*" ·, 9.60)
IR (KBr/cm-1): 3396 (γΝ-Η), 3288 (γΝ-Η), 1639 (yc=o), 1602, 1519, 1467 (yc=c), 1535 (γα=Ν), 1195 (Y=C-O-C) IR (KBr / cm- 1 ): 3396 (γ Ν-Η ), 3288 (γ Ν-Η ), 1639 (y c = o), 1602, 1519, 1467 (y c = c), 1535 (γ α = Ν ), 1195 (Y = COC)
E.A. for C26H23F2N504 Calcd: C 61.53, H 4.57, N 13.80 EA for C 26 H2 3 F 2 N 5 0 4 Calcd: C 61.53, H 4.57, N 13.80
Found: C 61.83, H 4.58, N 13.70 实施例 18 Found: C 61.83, H 4.58, N 13.70 Example 18
I -18的合成,, 详细实验步骤同实施例 1 : ( 1 ) 与水杨醛缩合: 投料量 7.12 mmol 氨基物,过滤得 1.649克亚胺物,收率理论量 63%。 (2 ) Schiff碱还原:投料量 4.49 mmol 亚胺物, 得 1.639克 (4.44 mmol)产品, 收率 99%。 (3 ) 与嘧啶砜缩合: 采用方法 b 来合成,投料量 1.639克(4.44 mmol )亚胺还原的产物,柱层析(石油醚:乙酸乙酯 = 2: 1 ) 得纯品, 收率 75%。  The synthesis of I-18. The detailed experimental steps are the same as in Example 1: (1) Condensation with salicylaldehyde: 7.12 mmol of amino compound was filtered, and 1.649 g of imine was obtained by filtration. The theoretical yield was 63%. (2) Schiff base reduction: 1.49 g (4.44 mmol) of the imide is charged in an amount of 4.49 mmol, and the yield is 99%. (3) Condensation with pyrimidine sulfone: Synthesized by method b, 1.639 g (4.44 mmol) of the imine-reduced product was charged, and column chromatography (petroleum ether: ethyl acetate = 2: 1) was obtained in pure form, yield 75 %.
Solid Solid
m.p.: 173.8±0.5 °C m.p .: 173.8 ± 0.5 ° C
'H NMR (300 MHz, CDCI3/TMS): δ 3.81 (6H, s, OCH3), 4.30 (2H, s, CH2), 5.78 (1H, s, CH), 6.30-7.43 (11H, m), 8.01 (2H, m, NH) 19FNMR (282 MHz, CDC13): δ -116.91 (IF, s), -126.46 (IF, s) 'H NMR (300 MHz, CDCI3 / TMS): δ 3.81 (6H, s, OCH 3 ), 4.30 (2H, s, CH 2 ), 5.78 (1H, s, CH), 6.30-7.43 (11H, m) , 8.01 (2H, m, NH) 19 FNMR (282 MHz, CDC1 3 ): δ -116.91 (IF, s), -126.46 (IF, s)
MS (EI): 151 in/z, 100), 474 (Μ+·, 22.71) MS (EI): 151 in / z, 100), 474 (Μ + ·, 22.71)
IR KBr/cm—1): 3375 (γΝ-Η), 3294 (γΝ-Η), 1611, 1573, 1526 (jc=c), 1236, 1219 (y=C-o-c) E.A. for C26H23F2N504 Calcd: C 61.53, H 4.57, N 13.80 IR KBr / cm— 1 ): 3375 (γ Ν-Η ), 3294 (γ Ν-Η ), 1611, 1573, 1526 (j c = c), 1236, 1219 (y = C -oc) EA for C 26 H 23 F 2 N 5 0 4 Calcd: C 61.53, H 4.57, N 13.80
Found: C 61.61, H 4.67, N 13.82 实施例 19 Found: C 61.61, H 4.67, N 13.82 Example 19
I -19的合成,详细实验步骤同实施例 1: (1)与 6-甲氧基水杨醛缩合:投料量 5 mmol 氨基物, 旋干后直接进入下一步, 收率 99%。 (2) Schiff碱还原: 投料量 5 mmol亚胺 物, 得 1.715克(4.5 mmol)产品, 收率 90%。 (3)与嘧啶砜缩合: 采用方法 b来合成, 投料量 0.758克(1.99 mmol)亚胺还原的产物, 柱层析(石油醚:乙酸乙酯 =2:1)得纯 品, 收率 75%。  The synthesis of I-19, the detailed experimental steps are the same as in Example 1: (1) Condensation with 6-methoxysalicylic aldehyde: Amount of 5 mmol of amino compound, spin-drying, and directly into the next step, the yield is 99%. (2) Schiff base reduction: Feed 5 mmol of imine to obtain 1.715 g (4.5 mmol) of the product with a yield of 90%. (3) Condensation with pyrimidine sulfone: Synthesized by method b. The input product is 0.758 g (1.99 mmol) of imine-reduced product. Column chromatography (petroleum ether: ethyl acetate = 2: 1) yields pure product. Yield: 75. %.
Solid Solid
m.p.:221.8±0.5°C m.p .: 221.8 ± 0.5 ° C
1H NMR (300 MHz, CDCI3/TMS): δ 3.78 (6H, s, OCH3), 3.88 (3H, s, OC¾), 4.33 (2H, s, CH2), 5.75 (1H, s, CH), 6.34-7.34 (12H, m) 1H NMR (300 MHz, CDCI3 / TMS): δ 3.78 (6H, s, OCH 3 ), 3.88 (3H, s, OC¾), 4.33 (2H, s, CH 2 ), 5.75 (1H, s, CH), 6.34-7.34 (12H, m)
19FNMR (282M, CDC13): -119.66 (IF, s) 1 9 FNMR (282M, CDC1 3 ): -119.66 (IF, s)
MS (EI): 275 (m/z, 100), 519 (M+, 33.19) MS (EI): 275 (m / z, 100), 519 (M + , 33.19)
IR (KBr/cm"1): 3384 (γΝH), 3323 (γΝ-Η), 1643 (yc=o), 1598, 1555, 1511 (yc=c), 1573 (yc=N), 1220, 1197, 1113 (Y=C-0-C) IR (KBr / cm " 1 ): 3384 (γ ΝH ), 3323 (γ Ν-Η ), 1643 (y c = o), 1598, 1555, 1511 (yc = c), 1573 (y c = N ), 1220, 1197, 1113 (Y = C-0 -C)
E.A. for C27H26FN505 Calcd: C 62.42, H 5.04, N 13.48 EA for C 27 H 26 FN 5 0 5 Calcd: C 62.42, H 5.04, N 13.48
Found: C 62.20, H 4.73, N 13.57 实施例 20 Found: C 62.20, H 4.73, N 13.57 Example 20
I -20的合成, 详细实验步骤同实施例 1: (1) 与 6-氟水杨醛缩合: 投料量 3.8 mmol氨 基物,旋干后直接进入下一步,收率 99%。 (2) Schiff碱还原:投料量 3.8 mmol亚胺物, 得 1.397克(3.61 mmol)产品, 收率 95%。 (3)与嘧啶砜缩合: 采用方法 b来合成, 投 料量 0.929克(2.4mmol)亚胺还原的产物, 柱层析(石油醚:乙酸乙酯 =2:1)得纯品, 收率 85%。  For the synthesis of I-20, the detailed experimental steps are the same as those in Example 1: (1) Condensation with 6-fluorosalicylic aldehyde: The feed amount is 3.8 mmol of amino, which is directly dried after spinning to the next step with a yield of 99%. (2) Schiff base reduction: 3.8 mmol of imine is charged to obtain 1.397 g (3.61 mmol) of the product with a yield of 95%. (3) Condensation with pyrimidine sulfone: Synthesized by method b, 0.929 g (2.4 mmol) of imine-reduced product, column chromatography (petroleum ether: ethyl acetate = 2: 1) to obtain pure product, yield 85 %.
Oil 1H NMR (300 MHz, CDC13/TMS): δ 0.97 (6H, t, CH3, J = 7.5Hz), 1.33-1.43 (4H, m, CH2): 1.55-1.65 (4H, m, CH2), 3.27 (4H, t, CH2, J= 7.5Hz), 3.79 (6H, s, OC¾), 4.35 (2H, s, CH2): 5.78 (1H, s, CH), 6.15-7.31 (8H, m) Oil 1H NMR (300 MHz, CDC1 3 / TMS): δ 0.97 (6H, t, CH 3 , J = 7.5Hz), 1.33-1.43 (4H, m, CH 2 ): 1.55-1.65 (4H, m, CH 2 ), 3.27 (4H, t, CH 2 , J = 7.5Hz), 3.79 (6H, s, OC¾), 4.35 (2H, s, CH 2 ): 5.78 (1H, s, CH), 6.15-7.31 (8H , m)
MS (EI): 245 (m/z, 100), 525 (M+', 10.24) MS (EI): 245 (m / z, 100), 525 (M + ', 10.24)
IR (KBr/cm-1): 3356 (γΝ-Η), 1645 (γ0=ο), 1604, 1540, 1470 (γ0=ο)5 1571 (γ=Ν), 1222, 1197, 1168 (T=c-o-c) IR (KBr / cm- 1 ): 3356 (γ Ν-Η ), 1645 (γ 0 = ο ), 1604, 1540, 1470 (γ 0 = ο) 5 1571 (γ = Ν ), 1222, 1197, 1168 ( T = c- oc)
Ε.Α. for C28H37N504 Calcd: C 63.98, H 6.90, N 13.32 Ε.Α. for C 28 H 37 N 5 0 4 Calcd: C 63.98, H 6.90, N 13.32
Found: C 64.36, H 7.14, N 13.06 实施例 21 . Found: C 64.36, H 7.14, N 13.06 Example 21.
以下实施例 21至实施例 25给出以本发明的化合物作为活性物质组份,加工配制几 种除草剂剂型的实际例子, 需要指出的是本发明并不仅仅局限在下述实例的范围内。  The following Examples 21 to 25 give practical examples of processing and formulating several herbicide formulations using the compound of the present invention as an active material component. It should be noted that the present invention is not limited to the scope of the following examples.
可湿性粉剂(WP)配方:将 15%的化合物(I一 1 ) (表一)、5%的木质素磺酸盐(Mq)、 1%的月桂醇聚氧乙烯醚(JFC)、 40%的硅藻土和 44%的轻质碳酸钙均匀地混合, 粉碎, 即得可湿性粉剂。 实施例 22 Wettable powder (WP) formula: 15% compound (I-1) (Table 1), 5% lignin sulfonate ( Mq ), 1% lauryl alcohol polyoxyethylene ether (JFC), 40 % Diatomaceous earth and 44% light calcium carbonate are evenly mixed and crushed to obtain a wettable powder. Example 22
乳油(EC)配方: 将 10%的化合物(1〜1 ) (表一)、 5%的农乳 500号(钙盐)、 5% 的农乳 602号、 5%的 N-甲基 -2-吡咯烷酮和 75%的二甲苯加热搅拌均匀,即得 10%乳油。 实施例 23  EC formula: 10% compound (1 ~ 1) (Table 1), 5% agricultural milk 500 (calcium salt), 5% agricultural milk 602, 5% N-methyl-2 -Pyrrolidone and 75% xylene are heated and stirred to obtain 10% emulsifiable concentrate. Example 23
颗粒剂(GR)配方: 将 5%的化合物(I一 1 ) (表一)、 1%的聚乙烯醇(PVA)、 4% 的萘磺酸钠甲醛缩合物(NMO ) 和 90%粘土均匀地混合, 粉碎, 然后向此 100份混合 物加入 20份水, 捏合, 用挤压成粒机, 制成 14一 32目的颗粒, 干燥, 即得 5%颗粒剂。 实施例 24  Granule (GR) formulation: 5% compound (I-1) (Table 1), 1% polyvinyl alcohol (PVA), 4% sodium naphthalenesulfonate formaldehyde condensate (NMO) and 90% clay are uniform It was mixed and pulverized, and then 20 parts of water was added to the 100 parts of the mixture, kneaded, and granulated by an extruder to obtain 14-32 mesh granules, and dried to obtain 5% granules. Example 24
水乳剂(EW)配方: 将 15%的化合物(I一 1 ) (表一)、 8%烷基芳基甲醛树脂聚氧 乙烯醚、 10%十二烷基苯磺酸钙、 3%十四垸醇、 10%二甲基甲酰胺、 5%丙二醇, 余量 为水, 根据各组分性质, 分别制成油相和水相, 然后在高速搅拌下, 将二者混合, 形成 分散性良好的 15%水乳剂。 实施例 25 Water emulsion (EW) formula: 15% of compound (I-1) (Table 1), 8% alkylaryl formaldehyde resin polyoxyethylene ether, 10% calcium dodecylbenzenesulfonate, 3% fourteen Methanol, 10% dimethylformamide, 5% propylene glycol, and the balance is water. According to the properties of each component, an oil phase and an aqueous phase are respectively prepared, and then the two are mixed under high speed stirring to form 15% water emulsion with good dispersibility. Example 25
水悬浮剂(SC)配方: 将 15%的化合物(1—1 ) (表一)、 5%的木质素磺酸钙、 0.5% 白碳黑、 4%乙二醇、 1%消泡剂、余量为水,加入砂磨釜中,研磨至一定细度, 制成 15% 悬浮剂。 实施例 26  Water suspension (SC) formula: 15% of the compound (1-1) (Table 1), 5% calcium lignosulfonate, 0.5% white carbon black, 4% ethylene glycol, 1% defoamer, The balance is water. Add it to a sand mill and grind to a certain fineness to make 15% suspension. Example 26
以下实施给出使用本发明的化合物进行生物活性测定的实例,需要指出的是本发明 并不仅仅局限在下述实例的范围内。  The following examples give examples of biological activity determination using the compounds of the present invention. It should be noted that the present invention is not limited to the scope of the following examples.
除草活性评价试验根据下列方法进行:  The herbicidal activity evaluation test was performed according to the following methods:
试验用土为配制的砂壤土, 除草活性试验用盆钵直径为 9.5cm, 安全性试验用盆钵 直径为 12.0cm。  The test soil was a prepared sandy loam soil. The diameter of the pot bowl for the herbicidal activity test was 9.5 cm, and the diameter of the pot bowl for the safety test was 12.0 cm.
芽前试验处理的盆钵在播种后一天进行土壤表面喷雾处理,处理的药液为化合物用 丙酮、 DMF等有机溶剂溶解, 并加入 0.5%吐温 -80的实验室制剂, 再加水稀释为需要 剂量。  The pre-emergence test pot was sprayed with soil surface one day after sowing. The treated liquid was the compound dissolved with organic solvents such as acetone and DMF, and 0.5% Tween-80 laboratory preparation was added, and then diluted with water as needed. dose.
芽后试验处理的盆钵在播种后放入温室培养 7~9天后, 进行叶面喷雾处理, 处理的 药液为化合物用丙酮、 DMF等有机溶剂溶解, 并加入 0.5%吐温 -80的实验室制剂, 再 加水稀释为需要剂量。  The post-emergence test pot was placed in the greenhouse for 7-9 days after sowing, and then foliar sprayed. The treated liquid was a compound dissolved with organic solvents such as acetone and DMF, and 0.5% Tween-80 was added. Chamber preparation, and diluted with water to the required dose.
第一次活性测定试验的化合物处理浓度为 300 gai/ha或 150gai/ha, 第二次活性测定 试验的化合物处理浓度为 75、 150和 300gai/ha或 37.5、 75、 150gai/ha。 处理的盆钵静 置 1天后, 放入温室, 定期浇水, 14~21天后目测法观察记录化合物的除草活性。  The compound treatment concentration in the first activity determination test was 300 gai / ha or 150 gai / ha, and the compound treatment concentration in the second activity determination test was 75, 150, and 300 gai / ha or 37.5, 75, 150 gai / ha. The treated pots were allowed to stand for 1 day, then placed in a greenhouse, and watered regularly. After 14 to 21 days, the herbicidal activity of the recorded compounds was observed visually.
以植物受害症状 (抑制、 畸形、 黄化、 白化)表现程度目测化合物的除草活性, 0 表示没有除草效果或对作物安全, 100%表示完全杀死杂草或作物。  The herbicidal activity of the compound was visually measured by the degree of plant damage symptoms (inhibition, malformation, yellowing, albinism). 0 means no herbicidal effect or safety to the crop, and 100% means complete weed or crop killing.
除草活性和作物安全性目测法评价标准如下:  The evaluation criteria of herbicidal activity and crop safety visual method are as follows:
植物毒性 除草活性评语 作物安全性评语  Phytotoxicity Herbicidal activity reviews Crop safety reviews
(%) (抑制、 畸形、 白化等) (抑制、 畸形、 白化等) (%) (Suppression, deformity, whitening, etc.) (Suppression, deformity, whitening, etc.)
0 同对照, 耐, 淘汰 同对照, 耐, 正常0 Same control, resistant, eliminated Same control, resistant, normal
10-20 轻, 稍有影响, 淘汰 轻, 稍有影响, 可考虑10-20 light, slightly affected, eliminated light, slightly affected, can be considered
30-40 轻, 有影响, 淘汰 敏感, 有影响, 淘汰 50-60 敏感, 有影响, 可考虑进一步改造 较敏感, 药害重, 淘汰30-40 light, influential, elimination, sensitive, influential, elimination 50-60 Sensitive and influential
70-80 较敏感, 可考虑 极敏感, 药害重, 淘汰70-80 is more sensitive, it can be considered extremely sensitive, serious drug damage, eliminated
90-100 极敏感, 好 极敏感, 药害重, 淘汰 第一次高剂量处理的除草活性试验结果见表 1、 表 2; 第二次降低剂量的除草活性 试验结果见表 3、 表 4; 作物安全性试验结果见表 5 90-100 is extremely sensitive, very sensitive, and severely harmful. The results of the first herbicidal activity test for eliminating the first high-dose treatment are shown in Table 1 and Table 2. Crop safety test results are shown in Table 5.
选择的生物活性测定试验用的杂草和作物种类如下:  The types of weeds and crops selected for the biological activity test are as follows:
中文名 英文名 科学名称 缩写 稗草 barnyardgrass Echinochloa crusgalli ECHCG 马唐 Crabgrass Digitaria sanguinalis DIGSA 牛筋草 Bullgrass Eleusine indica ELEIN 芥菜 Leaf mustard Brassicajuncea BRAJU 反枝苋 Amaranth pigweed Amaranthus retroflexus AMARE 马齿苋 Common purslane Portulaca oleracea POROL 玉米 Corn Zea mays ZEAMX 大豆 Soybean Glycine max GLXMA 棉花 Cotton Gossypium hispitum GOSHI 小麦 Wheat Triticum aestivum TRZAW 水稻 Rice Oryza sativa ORYSD 油菜 Rape Brassica napus BRSNW Chinese name English name Scientific name abbreviation barnyardgrass Echinochloa crusgalli ECHCG Crabgrass Digitaria sanguinalis DIGSA Bullgrass Eleusine indica ELEIN Mustard Leaf mustard Brassicajuncea BRAJU Portion Amaranth pigweed AcornORa coma mays ZEAMX Soybean Glycine max GLXMA Cotton Cotton Gossypium hispitum GOSHI Wheat Wheat Triticum aestivum TRZAW Rice Rice Oryza sativa ORYSD Rape Brassica napus BRSNW
表 1、 芽后茎叶处理的第一次除草活性试验结果 化合物 剂量 Table 1.Results of the first herbicidal activity test on post-emergence stem and leaf treatments.
稗草 马唐 牛筋草 反枝苋 马齿苋 编号 ( g ai/ha)  稗 草 Matang Goosegrass Anti-branch Purslane Number (g ai / ha)
1- 1 300 85 80 80 100 100 100 1- 1 300 85 80 80 100 100 100
1-2 300 100 85 100 90 100 1001-2 300 100 85 100 90 100 100
1-3 300 100 100 100 100 100 1001-3 300 100 100 100 100 100 100
1-4 300 100 100 100 100 100 901-4 300 100 100 100 100 100 90
1-5 300 100 85 100 95 100 951-5 300 100 85 100 95 100 95
1-6 300 100 100 100 100 100 1001-6 300 100 100 100 100 100 100
1-7 300 100 100 100 100 100 951-7 300 100 100 100 100 100 95
1-8 150 0 60 70 70 80 01-8 150 0 60 70 70 80 0
1-9 300 90 80 40 80 100 0 I一 10 150 85 95 80 100 100 1001-9 300 90 80 40 80 100 0 I one 10 150 85 95 80 100 100 100
I一 11 150 90 100 90 100 100 80I one 11 150 90 100 90 100 100 80
1—12 300 85 60 80 85 85 01-12 300 85 60 80 85 85 0
1-13 300 80 70 60 80 80 801-13 300 80 70 60 80 80 80
1-14 300 85 70 60 90 90 801-14 300 85 70 60 90 90 80
1-15 150 85 90 100 95 98 701-15 150 85 90 100 95 98 70
1-16 150 85 90 100 95 100 701-16 150 85 90 100 95 100 70
1-17 150 85 90 100 95 100 601-17 150 85 90 100 95 100 60
1-18 150 98 95 90 70 100 851-18 150 98 95 90 70 100 85
1-19 150 90 95 100 100 100 85 1-19 150 90 95 100 100 100 85
表 2: 芽前土壤处理的第一次除草活性试验结果 化合物 剂量 Table 2: Results of the first herbicidal activity test on pre-emergent soil treatment
稗草 牛筋草 反枝苋 马齿苋 编号 (g ai/ha)  Potamogeton spp.Easygrass Reeds Purslane Number (g ai / ha)
1-1 300 80 60 80 70 60 70 1-1 300 80 60 80 70 60 70
1-2 300 90 90 80 90 90 901-2 300 90 90 80 90 90 90
1-3 300 90 95 85 95 95 901-3 300 90 95 85 95 95 90
1-4 300 90 90 85 98 90 901-4 300 90 90 85 98 90 90
1—5 300 100 80 80 90 90 901-5 300 100 80 80 90 90 90
1-6 300 100 80 80 95 95 901-6 300 100 80 80 95 95 90
1-7 300 90 85 80 90 95 901-7 300 90 85 80 90 95 90
1-8 150 0 0 40 80 70 01-8 150 0 0 40 80 70 0
1-9 300 0 0 ― 60 0 01-9 300 0 0 ― 60 0 0
1-10 150 95 90 80 80 85 801-10 150 95 90 80 80 85 80
1-11 150 95 90 80 80 85 901-11 150 95 90 80 80 85 90
1-12 300 -- 50 ― 70 60 01-12 300-50 ― 70 60 0
1-13 300 50 70 ― 70 0 ―1-13 300 50 70 ― 70 0 ―
1-14 300 50 50 50 60 50 01-14 300 50 50 50 60 50 0
1-15 150 ― ― ― 80 90 801-15 150 ― ― ― 80 90 80
1-16 150 ― ― -- 85 90 801-16 150 ― ―-85 90 80
1-17 150 80 85 85 80 95 801-17 150 80 85 85 80 95 80
1-18 150 85 85 85 80 90 851-18 150 85 85 85 80 90 85
1-19 150 50 80 80 90 90 80 芽后茎叶处理的第二次除草活性大小评价结果 化合物 剂量 1-19 150 50 80 80 90 90 80 Results of the second evaluation of the herbicidal activity after the shoot and stem treatment
稗草 马唐 牛筋草 芥菜 反枝宽 马齿苋 编号 g ai/ha  Potamogeton crispus gluten, mustard grass, mustard, reverse branch, purslane number g ai / ha
75 80 50 85 80 100 80 75 80 50 85 80 100 80
1-1 150 90 85 100 85 100 85 1-1 150 90 85 100 85 100 85
300 95 90 100 100 100 100 300 95 90 100 100 100 100
75 100 80 85 70 100 4075 100 80 85 70 100 40
1-2 150 100 90 100 75 100 60 1-2 150 100 90 100 75 100 60
300 100 98 100 80 100 60 300 100 98 100 80 100 60
75 70 80 80 100 100 10075 70 80 80 100 100 100
1-3 150 100 85 80 100 100 50 1-3 150 100 85 80 100 100 50
300 100 100 80 100 100 100 300 100 100 80 100 100 100
75 100 85 90 95 100 8575 100 85 90 95 100 85
1-4 150 100 95 95 95 100 90 1-4 150 100 95 95 95 100 90
300 100 95 95 100 100 100 300 100 95 95 100 100 100
75 60 70 70 70 100 6075 60 70 70 70 100 60
1-5 150 100 80 100 70 100 60 1-5 150 100 80 100 70 100 60
300 100 85 100 75 100 75 300 100 85 100 75 100 75
75 90 95 100 100 100 9575 90 95 100 100 100 95
1-6 150 100 100 100 100 100 100 1-6 150 100 100 100 100 100 100
300 100 100 100 100 100 100 300 100 100 100 100 100 100
75 95 95 95 75 90 5075 95 95 95 75 90 50
1~7 150 95 95 95 80 90 60 1 ~ 7 150 95 95 95 80 90 60
300 100 95 95 90 100 90 300 100 95 95 90 100 90
37.5 0 0 60 60 60 4037.5 0 0 60 60 60 40
1-8 75 20 0 80 60 60 40 1-8 75 20 0 80 60 60 40
150 30 40 100 60 80 40 150 30 40 100 60 80 40
75 90 80 70 60 85 8075 90 80 70 60 85 80
1-9 150 95 85 80 100 100 100 1-9 150 95 85 80 100 100 100
300 100 85 80 100 100 100 300 100 85 80 100 100 100
1- 12 75 90 60 100 60 90 50 1- 12 75 90 60 100 60 90 50
150 90 90 100 85 100 80 300 100 100 100 90 100 80150 90 90 100 85 100 80 300 100 100 100 90 100 80
75 80 60 95 90 95 9075 80 60 95 90 95 90
1- 13 150 90 80 100 90 100 90 1- 13 150 90 80 100 90 100 90
300 98 95 100 100 100 100 300 98 95 100 100 100 100
75 90 80 100 90 100 7075 90 80 100 90 100 70
1- 14 150 90 80 100 90 100 40 1- 14 150 90 80 100 90 100 40
300 100 100 100 100 100 80 300 100 100 100 100 100 80
37.5 60 70 60 30 60 037.5 60 70 60 30 60 0
1- 15 75 70 70 80 40' 80 30 1- 15 75 70 70 80 40 '80 30
150 85 75 90 50 80 30 150 85 75 90 50 80 30
37.5 70 60 80 30 80 037.5 70 60 80 30 80 0
1- 16 75 90 80 100 40 100 0 1- 16 75 90 80 100 40 100 0
150 95 85 100 60 100 30 150 95 85 100 60 100 30
37.5 50 50 80 50 65 037.5 50 50 80 50 65 0
1- 17 75 70 60 100 70 80 30 1- 17 75 70 60 100 70 80 30
150 80 80 100 80 80 40 150 80 80 100 80 80 40
37.5 75 60 70 20 80 037.5 75 60 70 20 80 0
1- 18 75 80 75 80 30 90 0 1- 18 75 80 75 80 30 90 0
150 85 80 90 50 100 70 150 85 80 90 50 100 70
37.5 80 75 100 60 80 037.5 80 75 100 60 80 0
1- 19 75 100 90 100 70 80 60 1- 19 75 100 90 100 70 80 60
150 100 100 100 75 80 75  150 100 100 100 75 80 75
表 4: 芽前土壤处理的第二次除草活性大小评价结果 化合物 剂量 Table 4: Evaluation results of the second herbicidal activity in pre-emergent soil treatment
稗草 牛筋草 介米 反枝宽 马齿苋 编号 g ai/ha  Echinochloa crusgalli, Tendon serrata, rice branch width, purslane number g ai / ha
75 40 40 40 80 90 90 75 40 40 40 80 90 90
1- 1 150 80 70 60 80 90 80 1- 1 150 80 70 60 80 90 80
300 95 90 90 90 95 95 300 95 90 90 90 95 95
75 60 60 60 60 85 7075 60 60 60 60 85 70
1-2 150 60 70 60 60 85 80 1-2 150 60 70 60 60 85 80
300 80 80 80 70 95 85 300 80 80 80 70 95 85
1-3 75 60 90 70 95 90 90 6c 1-3 75 60 90 70 95 90 90 6c
Figure imgf000031_0001
Z.000/l700ZN3/X3d 890/S00Z OAV 37.5 40 70 70 70 85 70
Figure imgf000031_0001
Z.000 / l700ZN3 / X3d 890 / S00Z OAV 37.5 40 70 70 70 85 70
1- 16 75 80 85 80 85 90 80 1- 16 75 80 85 80 85 90 80
150 85 90 90 90 95 85 150 85 90 90 90 95 85
37.5 ― ― -- 50 20 037.5 ― ―-50 20 0
1- 17 75 ― ― - 70 80 80 1- 17 75 ― ―-70 80 80
150 85 90 80 75 90 80 150 85 90 80 75 90 80
37.5 50 60 60 75 80 6037.5 50 60 60 75 80 60
1- 18 75 80 70 75 80 90 70 1- 18 75 80 70 75 80 90 70
150 85 80 75 80 95 80 150 85 80 75 80 95 80
37.5 0 60 60 90 95 6037.5 0 60 60 90 95 60
1- 19 75 60 70 70 90 95 75 1- 19 75 60 70 70 90 95 75
150 70 90 75 95 100 80  150 70 90 75 95 100 80
表 5 : 苗后叶面处理的作物安全性试验结果 Table 5: Crop safety test results of post-emergence foliar treatment
化合物 剂量 玉米 大豆 棉花 油菜 水稻 Compound dose corn soybean cotton rapeseed rice
(g ai/ha)  (g ai / ha)
37.5 20 10 10 20 20 0 37.5 20 10 10 20 20 0
1-5 75 40 30 10 30 20 20 1-5 75 40 30 10 30 20 20
150 40 50 50 50 20 30 150 40 50 50 50 20 30
37.5 60 10 20 0 30 2037.5 60 10 20 0 30 20
1-7 75 60 10 20 30 30 30 1-7 75 60 10 20 30 30 30
150 90 20 50 30 30 40 150 90 20 50 30 30 40
37.5 20 30 10 20 10 2037.5 20 30 10 20 10 20
1-9 75 30 30 50 30 10 20 1-9 75 30 30 50 30 10 20
150 40 70 80 40 70 60 150 40 70 80 40 70 60
37.5 50 0 0 0 ― 1037.5 50 0 0 0 ― 10
1- 12 1- 12
75 50 40 30 20 ― 30 75 50 40 30 20 ― 30
37.5 0 0 20 30 50 2037.5 0 0 20 30 50 20
1- 14 1- 14
75 30 0 40 40 50 60  75 30 0 40 40 50 60

Claims

权 利 要 求 Rights request
1、 一种化合物, 其结构通式如下 (I): 1. A compound whose structure is as follows (I):
Figure imgf000033_0001
其中: D或 E =氢、 卤素、 —C4烷基、 d—C4垸氧基、 —C4卤代烷基或 —C^ 卤代焼氧基;
Figure imgf000033_0001
Where: D or E = hydrogen, halogen, —C 4 alkyl, d—C 4 alkoxy, —C 4 haloalkyl, or —C ^ halofluorenoxy;
X=氢、 卤素、 硝基、 氰基、 羧基、 酯基、 磺酰基、 C广 C8烷基、 C「C8卤代垸基、 一 Cs垸氧基、 — 垸酰基、 d—C8烷酰氨基、 d—C8卤代烷酰氨基、 苯基、 苯并基、 取代苯基、 杂环基或取代杂环基; X = hydrogen, halogen, nitro, cyano, carboxyl, ester group, a sulfonyl group, wide C C 8 alkyl, C "embankment C 8 haloalkyl group, a C s embankment group, - embankment acyl, d-C 8 alkanoylamino, d-C 8 haloalkanoylamino, phenyl, benzoyl, substituted phenyl, heterocyclyl or substituted heterocyclyl;
Ri , R2=氢、 酯基、 磺酰基、 —C8烷基、 取代的 d—C8取代烷基、 d—C8垸氧基、 一¾垸酰基、苯基、杂环基或取代杂环基, 或者 , 相连为 -(CH2)mZ(CH2)k -,其中 Z 为 CH2、 NH、 O或 S, m、 k为 1〜6的整数; Ri, R 2 = hydrogen, ester group, sulfonyl, —C 8 alkyl, substituted d—C 8 substituted alkyl, d—C 8 alkoxy, ¾ acyl, phenyl, heterocyclic or substituted A heterocyclic group, or,-(CH 2 ) m Z (CH 2 ) k- , wherein Z is CH 2 , NH, O, or S, and m and k are integers of 1 to 6;
X'为 H、 、 卤素原子、 羧基、 酯基、 — 烷酰基、 d— C8烷基、 d
Figure imgf000033_0002
X 'is H,, halogen atom, carboxyl, ester, —alkanoyl, d—C 8 alkyl, d
Figure imgf000033_0002
一 C8卤代烷基、 d—C8垸氧基、 苯基、 取代苯基、 杂环基或取代杂环基; A C 8 haloalkyl, d-C 8 alkoxy, phenyl, substituted phenyl, heterocyclyl or substituted heterocyclyl;
n为 1到 4的整数; n is an integer from 1 to 4;
R3=氢、 烷酰基、 —C8卤代烷酰基、 苯甲酰基、 取代苯甲酰基、 d—Cs垸基。 R 3 = hydrogen, alkanoyl, —C 8 haloalkanoyl, benzoyl, substituted benzoyl, d-Csfluorenyl.
2、 如权利要求 1所述的化合物, 其结构式如下-
Figure imgf000034_0001
2. The compound according to claim 1, wherein its structural formula is as follows −
Figure imgf000034_0001
其中 D、 E、 X、 、 如权利要求 1所述。 Wherein D, E, X, and are as described in claim 1.
3、 如权利要求 1或 2所述的化合物, 其特征是所述的结构式中, 其中 D和 E两者 均为甲氧基。  3. The compound according to claim 1 or 2, wherein in the structural formula, both D and E are methoxy groups.
4、 如权利要求 1所述的化合物, 其特征是所述的结构式中, 所述的杂环基是吡啶 基、 噻吩基、 噻唑基或嘧啶基; 所述的取代垸基上的取代基是卤代或 Q~C8的烷氧基; 所述的取代苯基、 取代杂环基或取代苯甲酰基为单取代、二取代或多取代的, 所述的取 代基为卤素、 硝基、 氰基、 羧基、 酯基、 磺酰基、 d—C8垸基、 d—C8卤代烷基、 一 ¾烷氧基、 一 烷酰基或61—¾烷酰氨基。 4. The compound according to claim 1, wherein in the structural formula, the heterocyclic group is pyridyl, thienyl, thiazolyl, or pyrimidinyl; the substituent on the substituted fluorenyl is Halogenated or Q ~ C 8 alkoxy; said substituted phenyl, substituted heterocyclyl or substituted benzoyl are mono-, di- or poly-substituted, said substituents are halogen, nitro, Cyano, carboxyl, ester, sulfonyl, d-C 8 fluorenyl, d-C 8 haloalkyl, mono-alkoxy, mono-alkanoyl or 6 1- ¾-alkanoylamino.
5、 制备如权利要求 1所述的化合物的方法, 其特征通过下述方法制得:  5. A method for preparing a compound according to claim 1, characterized in that it is prepared by the following method:
由具有如下结构通式 (IV)的化合物  Compounds of the general formula (IV)
Figure imgf000034_0002
Figure imgf000034_0002
(IV)  (IV)
式中 Χ,Χ',η, 和 如权利要求 1所述,  Where χ, χ ′, η, and as described in claim 1,
在碱的存在下, 在或不在溶剂中, 与具有如下结构通式的嘧啶反应
Figure imgf000034_0003
In the presence of a base, in or without a solvent, reacts with a pyrimidine having the general structure
Figure imgf000034_0003
式中 D和 E如权利要求 1所述, Y代表卤素或甲砜基。  Wherein D and E are as described in claim 1, and Y represents halogen or methylsulfone.
6、如权利要求 5所述的制备方法,其特征所述的反应是在有机溶剂中,化合物(IV) 与 2-卤代 -4-D,6-E-取代嘧啶或 2-甲砜基 -4-D,6-E-取代嘧啶在碱的存在下反应 0.5到 20 小时, 化合物 (IV)、 2-卤代 -4-D,6-E-取代嘧啶或 2-甲砜基 -4-D,6-E-取代嘧啶和碱的摩 尔比为 1 : ( 1.0- 1.2): ( 1一 5),所述的碱是一价或二价金属的氢化物、烷氧金属化合物 或其碳酸盐、 三乙胺、 吡啶 , 反应温度为室温至溶剂沸点, 其中化合物 (IV)、 D、 E 如权利要求 5所示。 6. The preparation method according to claim 5, wherein the reaction is that the compound (IV) is reacted with 2-halo-4-D, 6-E-substituted pyrimidine or 2-methylsulfone in an organic solvent. -4-D, 6-E-substituted pyrimidine is reacted in the presence of a base for 0.5 to 20 hours. Compound (IV), 2-halo-4-D, 6-E-substituted pyrimidine or 2-methylsulfanyl-4 -D, 6-E-Substituted pyrimidine and base The molar ratio is 1: (1.0-1.2): (1-5), the base is a hydride of a monovalent or divalent metal, an alkoxy metal compound or a carbonate thereof, triethylamine, pyridine, and a reaction temperature. The temperature is from room temperature to the boiling point of the solvent, wherein compounds (IV), D, and E are as shown in claim 5.
7、 如权利要求 5或 6所述的制备方法, 其特征是进一步包括如下步骤 (2)或如下步 骤 (1)、 (2):  7. The preparation method according to claim 5 or 6, further comprising the following steps (2) or the following steps (1) and (2):
( 1 )在溶剂中, 在或不在催化剂作用下, 1-氨基苯基 -3-取代脲 (11)、 取代水杨醛 与催化剂反应, 制得中间体 (111), 所述的催化剂是对甲基苯磺酸、 甲磺酸、 硫酸、 盐 酸或醋酸 ;  (1) In a solvent, with or without the catalyst, 1-aminophenyl-3-substituted urea (11) and substituted salicylaldehyde are reacted with the catalyst to obtain an intermediate (111). The catalyst is Toluenesulfonic acid, methanesulfonic acid, sulfuric acid, hydrochloric acid or acetic acid;
(2)反应物(III)与还原剂反应制得化合物(IV), 所述的还原剂是硼氢化钠或硼 氢化钾;  (2) reacting the reactant (III) with a reducing agent to obtain a compound (IV), the reducing agent is sodium borohydride or potassium borohydride;
或反应物 (in)在催化剂的作用下, 用氢气还原化合物 (in) 制得化合物 αν), 催化剂是雷式镍(Raney Ni)、 钯碳或铂黑;  Or the reactant (in) is reduced by a hydrogen to produce the compound αν) under the action of a catalyst, and the catalyst is Raney Ni, palladium carbon or platinum black;
上述的 N—酰氨基苯胺(11)、 中间体(III)和化合物(IV)结构式分别依次如下所  The structural formulas of the aforementioned N-amidoaniline (11), intermediate (III) and compound (IV) are as follows respectively.
Figure imgf000035_0001
Figure imgf000035_0001
(IV)  (IV)
其中, D、 E、 X、 X'、 n、 、 R2或所述的 2—嘧啶氧基一 N—脲基苯基苄胺类化合物 如权利要求 1所示。 Wherein, D, E, X, X ', n,, R 2 or the 2-pyrimidinyloxy-N-ureidophenylbenzylamine compound is as shown in claim 1.
8、 如权利要求 7所述的制备方法, 其特征是所述的步骤 (1)、 (2)如下:  8. The preparation method according to claim 7, wherein the steps (1) and (2) are as follows:
( 1 )在溶剂中和反应温度为室温至溶剂沸点, 在或不在催化剂作用下, 1-氨基苯 基 -3-取代脲 (II ) 与水杨醛或取代水杨醛反应, 摩尔比为 1 : ( 0.8— 2 ), 反应 0.5到 12小时制得中间体 απ), 所述的催化剂是对甲基苯磺酸、 甲磺酸、 硫酸、 盐酸或醋酸 ; (1) In a solvent, the reaction temperature is from room temperature to the boiling point of the solvent, and 1-aminophenyl-3-substituted urea (II) is reacted with salicylaldehyde or substituted salicylaldehyde with or without a catalyst, and the molar ratio is 1 : (0.8— 2), Intermediate απ) is obtained by reacting for 0.5 to 12 hours, and the catalyst is p-toluenesulfonic acid, methanesulfonic acid, sulfuric acid, hydrochloric acid or acetic acid;
(2) 反应物 (ΠΙ) 与还原剂的摩尔比为 1 :0.5—2, 反应温度为室温至摄氏 40度, 反应 0.5至 10小时制得中间体(IV), 所述的还原剂是硼氢化钠或硼氢化钾;  (2) The molar ratio of the reactant (II) to the reducing agent is 1: 0.5-2, the reaction temperature is from room temperature to 40 degrees Celsius, and the intermediate (IV) is prepared by reacting for 0.5 to 10 hours, and the reducing agent is boron Sodium hydride or potassium borohydride;
或反应物 (ΠΙ)在催化剂的作用下, 用氢气还原化合物 (111), 在室温至摄氏 40 度反应 0.5至 10小时制得中间体 (IV), 催化剂是雷式镍 (Raney Ni)、 钯碳或铂黑 , 反应物 (111)、 氢气与催化剂的摩尔比为 1 : ( 1 - 1000): (0.01 -0.5); Or, the reactant (II) is reduced to compound (111) with hydrogen under the action of a catalyst, and reacted at room temperature to 40 degrees Celsius for 0.5 to 10 hours to obtain an intermediate (IV). The catalyst is Ra ne y Ni , Palladium on carbon or platinum black, the molar ratio of reactant (111), hydrogen to catalyst is 1: (1-1000): (0.01 -0.5);
上述的 N—酰氨基苯胺 (11)、 中间体(III)和中间体 (IV) 结构式如权利要求 7所述。 The N-amidoaniline (11), the intermediate (III) and the intermediate (IV) have the structural formulas as described in claim 7.
9、 如权利要求 5所述的制备方法, 其特征最终产物经硅胶柱层析或重结晶纯化。  9. The preparation method according to claim 5, characterized in that the final product is purified by silica gel column chromatography or recrystallization.
10、用作农用化学除草剂的农药组合物, 其中含有权利要求 1化合物和除草上可接 受的载体。  10. A pesticide composition for use as an agricultural chemical herbicide, comprising the compound of claim 1 and an acceptable carrier for herbicide control.
11、 一种如权利要求 1所述的化合物的用途, 其特征是用于农用化学除草剂。  11. Use of a compound according to claim 1, characterized in that it is used in agricultural chemical herbicides.
PCT/CN2004/000720 2003-07-04 2004-07-02 2-pyrimidionxy-n-carbamidophenylbenzylamine compounds and processes of the preparation thereof and the use of the same WO2005068434A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN 03141415 CN1208325C (en) 2003-07-04 2003-07-04 2-pyrimidine oxy-N-ureido phenyl-benzyl amide compound, preparing method and use thereof
CN03141415.X 2003-07-04

Publications (1)

Publication Number Publication Date
WO2005068434A1 true WO2005068434A1 (en) 2005-07-28

Family

ID=34155295

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2004/000720 WO2005068434A1 (en) 2003-07-04 2004-07-02 2-pyrimidionxy-n-carbamidophenylbenzylamine compounds and processes of the preparation thereof and the use of the same

Country Status (2)

Country Link
CN (1) CN1208325C (en)
WO (1) WO2005068434A1 (en)

Cited By (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013040117A1 (en) 2011-09-13 2013-03-21 Monsanto Technology Llc Methods and compositions for weed control
WO2013040021A1 (en) 2011-09-13 2013-03-21 Monsanto Technology Llc Methods and compositions for weed control
WO2013039990A1 (en) 2011-09-13 2013-03-21 Monsanto Technology Llc Methods and compositions for weed control
WO2013040049A1 (en) 2011-09-13 2013-03-21 Monsanto Technology Llc Methods and compositions for weed control
WO2014151255A1 (en) 2013-03-15 2014-09-25 Monsanto Technology Llc Methods and compositions for weed control
WO2015108982A2 (en) 2014-01-15 2015-07-23 Monsanto Technology Llc Methods and compositions for weed control using epsps polynucleotides
US9121022B2 (en) 2010-03-08 2015-09-01 Monsanto Technology Llc Method for controlling herbicide-resistant plants
US9416363B2 (en) 2011-09-13 2016-08-16 Monsanto Technology Llc Methods and compositions for weed control
US9422557B2 (en) 2011-09-13 2016-08-23 Monsanto Technology Llc Methods and compositions for weed control
US9540642B2 (en) 2013-11-04 2017-01-10 The United States Of America, As Represented By The Secretary Of Agriculture Compositions and methods for controlling arthropod parasite and pest infestations
US9777288B2 (en) 2013-07-19 2017-10-03 Monsanto Technology Llc Compositions and methods for controlling leptinotarsa
US9850496B2 (en) 2013-07-19 2017-12-26 Monsanto Technology Llc Compositions and methods for controlling Leptinotarsa
US10041068B2 (en) 2013-01-01 2018-08-07 A. B. Seeds Ltd. Isolated dsRNA molecules and methods of using same for silencing target molecules of interest
US10240161B2 (en) 2012-05-24 2019-03-26 A.B. Seeds Ltd. Compositions and methods for silencing gene expression
US10378012B2 (en) 2014-07-29 2019-08-13 Monsanto Technology Llc Compositions and methods for controlling insect pests
US10557138B2 (en) 2013-12-10 2020-02-11 Beeologics, Inc. Compositions and methods for virus control in Varroa mite and bees
US10609930B2 (en) 2013-03-13 2020-04-07 Monsanto Technology Llc Methods and compositions for weed control
US10612019B2 (en) 2013-03-13 2020-04-07 Monsanto Technology Llc Methods and compositions for weed control
US10655136B2 (en) 2015-06-03 2020-05-19 Monsanto Technology Llc Methods and compositions for introducing nucleic acids into plants
US10683505B2 (en) 2013-01-01 2020-06-16 Monsanto Technology Llc Methods of introducing dsRNA to plant seeds for modulating gene expression
US10760086B2 (en) 2011-09-13 2020-09-01 Monsanto Technology Llc Methods and compositions for weed control
US10801028B2 (en) 2009-10-14 2020-10-13 Beeologics Inc. Compositions for controlling Varroa mites in bees
US10806146B2 (en) 2011-09-13 2020-10-20 Monsanto Technology Llc Methods and compositions for weed control
US10808249B2 (en) 2011-09-13 2020-10-20 Monsanto Technology Llc Methods and compositions for weed control
US10829828B2 (en) 2011-09-13 2020-11-10 Monsanto Technology Llc Methods and compositions for weed control
US10883103B2 (en) 2015-06-02 2021-01-05 Monsanto Technology Llc Compositions and methods for delivery of a polynucleotide into a plant
US10888579B2 (en) 2007-11-07 2021-01-12 Beeologics Inc. Compositions for conferring tolerance to viral disease in social insects, and the use thereof
US10968449B2 (en) 2015-01-22 2021-04-06 Monsanto Technology Llc Compositions and methods for controlling Leptinotarsa
US10988764B2 (en) 2014-06-23 2021-04-27 Monsanto Technology Llc Compositions and methods for regulating gene expression via RNA interference
US11091770B2 (en) 2014-04-01 2021-08-17 Monsanto Technology Llc Compositions and methods for controlling insect pests
US11807857B2 (en) 2014-06-25 2023-11-07 Monsanto Technology Llc Methods and compositions for delivering nucleic acids to plant cells and regulating gene expression

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100361978C (en) * 2005-09-02 2008-01-16 中国科学院上海有机化学研究所 2-pyrimidine oxy-N-aryl 7-nitrile or organic phosphate benzylamine compound, its production and use thereof
CN108675945B (en) * 2018-06-22 2020-09-22 湖南科技大学 ((2-hydroxybenzyl) amido) phenylurea compound and preparation method and application thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4248619A (en) * 1978-08-08 1981-02-03 Ici Australia Limited Bis[pyrimidyloxy(thio)]benzene derivatives
US4427437A (en) * 1977-09-13 1984-01-24 Ici Australia Limited Use of 2-phenoxypyrimidines as herbicides
EP0321846A2 (en) * 1987-12-22 1989-06-28 Kumiai Chemical Industry Co., Ltd. Pyrimidine derivatives, processes for their production, and herbicidal method and compositions
CN1347876A (en) * 2001-04-20 2002-05-08 中国科学院上海有机化学研究所 2-pyrimidyloxybenzyl substituted naphthyl amine derivative and its synthesis and use
CN1348690A (en) * 2000-10-16 2002-05-15 浙江省化工研究院 2-pyrimioxybenzyl substituted phenyl amine derivatives

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4427437A (en) * 1977-09-13 1984-01-24 Ici Australia Limited Use of 2-phenoxypyrimidines as herbicides
US4248619A (en) * 1978-08-08 1981-02-03 Ici Australia Limited Bis[pyrimidyloxy(thio)]benzene derivatives
EP0321846A2 (en) * 1987-12-22 1989-06-28 Kumiai Chemical Industry Co., Ltd. Pyrimidine derivatives, processes for their production, and herbicidal method and compositions
CN1348690A (en) * 2000-10-16 2002-05-15 浙江省化工研究院 2-pyrimioxybenzyl substituted phenyl amine derivatives
CN1347876A (en) * 2001-04-20 2002-05-08 中国科学院上海有机化学研究所 2-pyrimidyloxybenzyl substituted naphthyl amine derivative and its synthesis and use

Cited By (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10888579B2 (en) 2007-11-07 2021-01-12 Beeologics Inc. Compositions for conferring tolerance to viral disease in social insects, and the use thereof
US10801028B2 (en) 2009-10-14 2020-10-13 Beeologics Inc. Compositions for controlling Varroa mites in bees
US11812738B2 (en) 2010-03-08 2023-11-14 Monsanto Technology Llc Polynucleotide molecules for gene regulation in plants
US9988634B2 (en) 2010-03-08 2018-06-05 Monsanto Technology Llc Polynucleotide molecules for gene regulation in plants
US9121022B2 (en) 2010-03-08 2015-09-01 Monsanto Technology Llc Method for controlling herbicide-resistant plants
EP3296402A2 (en) 2011-09-13 2018-03-21 Monsanto Technology LLC Methods and compositions for weed control
WO2013040117A1 (en) 2011-09-13 2013-03-21 Monsanto Technology Llc Methods and compositions for weed control
US9416363B2 (en) 2011-09-13 2016-08-16 Monsanto Technology Llc Methods and compositions for weed control
US9422557B2 (en) 2011-09-13 2016-08-23 Monsanto Technology Llc Methods and compositions for weed control
US9422558B2 (en) 2011-09-13 2016-08-23 Monsanto Technology Llc Methods and compositions for weed control
US10760086B2 (en) 2011-09-13 2020-09-01 Monsanto Technology Llc Methods and compositions for weed control
WO2013040049A1 (en) 2011-09-13 2013-03-21 Monsanto Technology Llc Methods and compositions for weed control
EP3434780A1 (en) 2011-09-13 2019-01-30 Monsanto Technology LLC Methods and compositions for weed control
US10829828B2 (en) 2011-09-13 2020-11-10 Monsanto Technology Llc Methods and compositions for weed control
WO2013040021A1 (en) 2011-09-13 2013-03-21 Monsanto Technology Llc Methods and compositions for weed control
WO2013039990A1 (en) 2011-09-13 2013-03-21 Monsanto Technology Llc Methods and compositions for weed control
US10806146B2 (en) 2011-09-13 2020-10-20 Monsanto Technology Llc Methods and compositions for weed control
EP3382027A2 (en) 2011-09-13 2018-10-03 Monsanto Technology LLC Methods and compositions for weed control
US10808249B2 (en) 2011-09-13 2020-10-20 Monsanto Technology Llc Methods and compositions for weed control
EP3434779A1 (en) 2011-09-13 2019-01-30 Monsanto Technology LLC Methods and compositions for weed control
US10240161B2 (en) 2012-05-24 2019-03-26 A.B. Seeds Ltd. Compositions and methods for silencing gene expression
US10240162B2 (en) 2012-05-24 2019-03-26 A.B. Seeds Ltd. Compositions and methods for silencing gene expression
US10934555B2 (en) 2012-05-24 2021-03-02 Monsanto Technology Llc Compositions and methods for silencing gene expression
US10041068B2 (en) 2013-01-01 2018-08-07 A. B. Seeds Ltd. Isolated dsRNA molecules and methods of using same for silencing target molecules of interest
US10683505B2 (en) 2013-01-01 2020-06-16 Monsanto Technology Llc Methods of introducing dsRNA to plant seeds for modulating gene expression
US10612019B2 (en) 2013-03-13 2020-04-07 Monsanto Technology Llc Methods and compositions for weed control
US10609930B2 (en) 2013-03-13 2020-04-07 Monsanto Technology Llc Methods and compositions for weed control
WO2014151255A1 (en) 2013-03-15 2014-09-25 Monsanto Technology Llc Methods and compositions for weed control
US10568328B2 (en) 2013-03-15 2020-02-25 Monsanto Technology Llc Methods and compositions for weed control
US9850496B2 (en) 2013-07-19 2017-12-26 Monsanto Technology Llc Compositions and methods for controlling Leptinotarsa
US9777288B2 (en) 2013-07-19 2017-10-03 Monsanto Technology Llc Compositions and methods for controlling leptinotarsa
US10597676B2 (en) 2013-07-19 2020-03-24 Monsanto Technology Llc Compositions and methods for controlling Leptinotarsa
US11377667B2 (en) 2013-07-19 2022-07-05 Monsanto Technology Llc Compositions and methods for controlling Leptinotarsa
US9856495B2 (en) 2013-07-19 2018-01-02 Monsanto Technology Llc Compositions and methods for controlling Leptinotarsa
US9540642B2 (en) 2013-11-04 2017-01-10 The United States Of America, As Represented By The Secretary Of Agriculture Compositions and methods for controlling arthropod parasite and pest infestations
US10100306B2 (en) 2013-11-04 2018-10-16 Monsanto Technology Llc Compositions and methods for controlling arthropod parasite and pest infestations
US10927374B2 (en) 2013-11-04 2021-02-23 Monsanto Technology Llc Compositions and methods for controlling arthropod parasite and pest infestations
US10557138B2 (en) 2013-12-10 2020-02-11 Beeologics, Inc. Compositions and methods for virus control in Varroa mite and bees
US10334848B2 (en) 2014-01-15 2019-07-02 Monsanto Technology Llc Methods and compositions for weed control using EPSPS polynucleotides
WO2015108982A2 (en) 2014-01-15 2015-07-23 Monsanto Technology Llc Methods and compositions for weed control using epsps polynucleotides
US11091770B2 (en) 2014-04-01 2021-08-17 Monsanto Technology Llc Compositions and methods for controlling insect pests
US10988764B2 (en) 2014-06-23 2021-04-27 Monsanto Technology Llc Compositions and methods for regulating gene expression via RNA interference
US11807857B2 (en) 2014-06-25 2023-11-07 Monsanto Technology Llc Methods and compositions for delivering nucleic acids to plant cells and regulating gene expression
US11124792B2 (en) 2014-07-29 2021-09-21 Monsanto Technology Llc Compositions and methods for controlling insect pests
US10378012B2 (en) 2014-07-29 2019-08-13 Monsanto Technology Llc Compositions and methods for controlling insect pests
US10968449B2 (en) 2015-01-22 2021-04-06 Monsanto Technology Llc Compositions and methods for controlling Leptinotarsa
US10883103B2 (en) 2015-06-02 2021-01-05 Monsanto Technology Llc Compositions and methods for delivery of a polynucleotide into a plant
US10655136B2 (en) 2015-06-03 2020-05-19 Monsanto Technology Llc Methods and compositions for introducing nucleic acids into plants

Also Published As

Publication number Publication date
CN1208325C (en) 2005-06-29
CN1488626A (en) 2004-04-14

Similar Documents

Publication Publication Date Title
WO2005068434A1 (en) 2-pyrimidionxy-n-carbamidophenylbenzylamine compounds and processes of the preparation thereof and the use of the same
AU2015366689B2 (en) Uracil compounds containing isoxazoline ring and the uses thereof
JPH02501309A (en) heterocyclic compound
WO2008145052A1 (en) Substituted pyrimidine ether compounds and their use
CN109071495B (en) Agricultural chemicals
WO2017036266A1 (en) 3-aryl pyridazinone, preparation method, pesticide composition and use
JPH1160562A (en) Sulfonanilide derivative and herbicide
WO2002034724A1 (en) New 2-pyrimidinyloxy-n-aryl-benzylamine derivatives, their processes and uses
Yoshimura et al. Synthesis and herbicidal activity of sulfonanilides having a pyrimidinyl-containing group at the 2′-position
JPH0539272A (en) Pyrimidinedione derivative and herbicide
JP2946656B2 (en) Uracil derivative and herbicide
BR112020015620A2 (en) PYRIDAZINOL COMPOUND WITH RING OF FIVE MEMBERS REPLACED AND ITS DERIVATIVES, METHOD OF PREPARATION, HERBICIDE COMPOSITION, AND APPLICATION
JPH0753718B2 (en) N-substituted-3- (substituted hydrazino) benzenesulfonamide derivative, process for producing the same and herbicide
US5266556A (en) Arylindazole derivatives and their use
CN112778192A (en) Polyfluoroalkyl-containing isoindolinone benzamide derivatives, and preparation method and application thereof
CN101381347B (en) Miazines compounds, preparation method and use thereof
CN101367769B (en) N-(2-pyrimidine oxygen based) benzyl amide compounds, preparation method and uses thereof
AU2018352160A1 (en) Benzimidazole compounds as agricultural chemicals
JP2730021B2 (en) 3-Benzyloxyalkanoic acid derivative, its production method and herbicide
JP4406155B2 (en) Benzoxazole derivatives, process for producing them and herbicides
JP3055207B2 (en) Pyrimidine derivatives and herbicides
CN101367766A (en) (2-pyrimidine oxygen base)benzaldehyde hydrazone compounds, preparation method and uses thereof
JPS63233977A (en) Pyrazole derivative, its production and herbicide containing said derivative as active component
JPH0517453A (en) Uracil derivative and herbicide
JPH07112972A (en) Pyrazolcarboxamine derivative, its production and agricultural/horticultural pest-controlling agent

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase